Eberhardt Ritz

Q: What Schools Are Affiliated With Eberhardt Ritz

Eberhardt Ritz is affiliated with the following schools: Heidelberg University, Medical University of Graz

Eberhardt Ritz's AcademicInfluence.com Rankings

Eberhardt Ritz

Philosophy

#2079

World Rank

#3627

Historical Rank

Logic

#425

World Rank

#808

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Eberhardt Ritz's Degrees

PhD Biomedical Sciences University of California, San Francisco
Doctorate Medicine Stanford University

Why Is Eberhardt Ritz Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Eberhardt Ritz's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. (2001) (5564)
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. (2005) (2435)
Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency (1996) (1606)
The Heidelberg classification of renal cell tumours (1997) (1125)
End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions. (1999) (799)
Association of a human G-protein β3 subunit variant with hypertension (1998) (791)
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). (2011) (786)
Nephropathy in patients with type 2 diabetes mellitus. (1999) (780)
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. (2011) (743)
Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. (2007) (696)
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial (2010) (678)
Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. (1996) (538)
Uric acid and chronic kidney disease: which is chasing which? (2013) (459)
Combining GFR and albuminuria to classify CKD improves prediction of ESRD. (2009) (421)
Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. (2000) (419)
Serum cystatin C concentration as a marker of renal dysfunction in the elderly. (2001) (416)
Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. (2002) (411)
Nephron number in patients with primary hypertension. (2003) (408)
Vitamin D status and arterial hypertension: a systematic review (2009) (396)
Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. (2002) (376)
Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations. (2005) (362)
Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. (1989) (345)
Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study. (2005) (344)
Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. (1998) (335)
Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. (2005) (332)
Myocyte/capillary mismatch in the heart of uremic patients. (1998) (324)
Smoking as a risk factor for end-stage renal failure in men with primary renal disease. (1998) (309)
Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications. (2005) (303)
Bone histology in incipient and advanced renal failure. (1976) (298)
[Nephrotic syndrome]. (1998) (294)
Similar risks of nephropathy in patients with type I or type II diabetes mellitus. (1989) (286)
Diffuse intermyocardiocytic fibrosis in uraemic patients. (1990) (279)
Diabetic nephropathy in type II diabetes. (1996) (271)
In situ production of TNF-α, IL-1β and IL-2R in ANCA-positive glomerulonephritis (1993) (271)
Vitamin D, cardiovascular disease and mortality (2011) (263)
1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia. (1989) (258)
Renal function in the elderly: impact of hypertension and cardiac function. (1997) (256)
A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. (1994) (253)
Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats. (1998) (248)
1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. (1993) (246)
Nutritional status in dialysis patients: a European consensus. (2002) (244)
Safety of ultrasound-guided percutaneous renal biopsy-retrospective analysis of 1090 consecutive cases. (1998) (239)
The effect of donor gender on graft survival. (2002) (238)
Avosentan reduces albumin excretion in diabetics with macroalbuminuria. (2009) (237)
Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure. (2000) (236)
Renal disease and hypertension in non-insulin-dependent diabetes mellitus. (1999) (236)
Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study. (2010) (235)
1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat. (2004) (231)
Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia. (2002) (227)
Renal functional reserve in healthy elderly subjects. (1993) (219)
The renal risks of smoking. (1997) (216)
Asymmetric Dimethylarginine, Blood Pressure, and Renal Perfusion in Elderly Subjects (2003) (214)
Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers. (2012) (213)
Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD. (2015) (212)
Renal function: the Cinderella of cardiovascular risk profile. (2001) (204)
Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats. (2000) (196)
Phosphate additives in food--a health risk. (2012) (194)
Uric Acid and Cardiovascular Events: A Mendelian Randomization Study. (2015) (193)
Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. (1995) (191)
Essential hypertension (2007) (187)
The arteriovenous fistula. (2003) (186)
Vasopressin: a novel target for the prevention and retardation of kidney disease? (2013) (182)
Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study (2008) (181)
Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kB (1999) (176)
Reduced capillary density in the myocardium of uremic rats--a stereological study. (1992) (172)
Calcium metabolism in early chronic renal failure: implications for the pathogenesis of hyperparathyroidism. (1991) (171)
Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia. (2003) (170)
Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure (1996) (169)
Homoarginine, Cardiovascular Risk, and Mortality (2010) (168)
Beta blockers in the management of chronic kidney disease. (2006) (167)
Myocardial interstitial fibrosis in experimental uremia--implications for cardiac compliance. (1988) (167)
Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation? (2003) (165)
Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography. (2010) (163)
Improvement of growth and food utilization by human recombinant growth hormone in uremia. (1988) (163)
Nephron number and renal risk in hypertension and diabetes. (2005) (161)
Vascular calcification: a stiff challenge for the nephrologist: does preventing bone disease cause arterial disease? (2004) (161)
Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats. (2003) (158)
Effects of smoking on renal hemodynamics in healthy volunteers and in patients with glomerular disease. (1998) (155)
Renal histology in polycystic kidney disease with incipient and advanced renal failure. (1992) (155)
Effect of Low-Dose Perindopril/Indapamide on Albuminuria in Diabetes: Preterax in Albuminuria Regression: PREMIER (2003) (155)
Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure. (1994) (155)
Cross-talk between the kidney and the cardiovascular system. (2006) (155)
The apolipoprotein e knockout mouse: a model documenting accelerated atherogenesis in uremia. (2003) (152)
Plasma aldosterone levels are associated with increased cardiovascular mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. (2010) (150)
Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors. (2003) (150)
High prevalence and poor control of hypertension in primary care: cross-sectional study (2004) (148)
Complement membrane attack (MAC) in idiopathic IgA-glomerulonephritis. (1987) (146)
Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients (2010) (144)
Calcification of coronary intima and media: immunohistochemistry, backscatter imaging, and x-ray analysis in renal and nonrenal patients. (2006) (139)
Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease. (2014) (138)
Changes of vascular architecture independent of blood pressure in experimental uremia. (1995) (137)
Renal findings in patients with short-term type 2 diabetes. (1996) (136)
Randomized Controlled Trial on the Efficacy and Safety of Atorvastatin in Patients with Type 2 Diabetes on Hemodialysis (4D Study): Demographic and Baseline Characteristics (2004) (135)
Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure:the effects of ramipril, nifedipine and moxonidine. (1996) (135)
The double challenge of resistant hypertension and chronic kidney disease (2015) (134)
ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy (2003) (133)
Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study. (2007) (132)
Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study. (2011) (132)
Coadministration of albumin and furosemide in patients with the nephrotic syndrome. (1999) (131)
Overview: increased cardiovascular risk in patients with minor renal dysfunction: an emerging issue with far-reaching consequences. (2004) (130)
Fluid phase generation of terminal complement complex as a novel index of bioincompatibility. (1990) (129)
Lysine-specific cleavage of beta 2-microglobulin in amyloid deposits associated with hemodialysis. (1989) (129)
The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group. (2000) (128)
Vena cava diameter measurement for estimation of dry weight in haemodialysis patients. (1996) (127)
Advanced glycated end-products (AGE) during haemodialysis treatment: discrepant results with different methodologies reflecting the heterogeneity of AGE compounds. (1999) (127)
Smoking and the kidney. (2002) (125)
Blood-pressure-independent wall thickening of intramyocardial arterioles in experimental uraemia: evidence for a permissive action of PTH. (1995) (124)
NON‐CORONARY HEART DISEASE IN DIALYSIS PATIENTS: Hypertrophy and Fibrosis in the Cardiomyopathy of Uremia—Beyond Coronary Heart Disease (2008) (122)
Serum creatinine, cystatin C, and beta-trace protein in diagnostic staging and predicting progression of primary nondiabetic chronic kidney disease. (2010) (122)
PDGF and TGF-β contribute to the natural course of human IgA glomerulonephritis (1995) (121)
Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products. (2005) (121)
The epidemiology of end-stage renal disease in Iran in an international perspective. (2002) (120)
The challenge of sudden death in dialysis patients. (2008) (120)
Is gender a determinant for evolution of renal failure? A study in autosomal dominant polycystic kidney disease. (1989) (119)
Lowering of microalbuminuria in diabetic patients by a sympathicoplegic agent: novel approach to prevent progression of diabetic nephropathy? (2001) (118)
Cardiac disease in chronic uremia: pathophysiology. (1997) (118)
Diminished parathyroid 1,25(OH)2D3 receptors in experimental uremia. (1987) (118)
B-type natriuretic peptide concentrations predict the progression of nondiabetic chronic kidney disease: the Mild-to-Moderate Kidney Disease Study. (2007) (117)
Early increase in blood pressure and diastolic left ventricular malfunction in patients with glomerulonephritis. (1996) (116)
Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis. (2011) (116)
No effect of calcitriol on insulin‐mediated glucose uptake in healthy subjects (1997) (115)
Frequency of mesangial IgA deposits in a non-selected autopsy series. (1989) (115)
Mechanism of Cephalosporin‐induced Hypoprothrombinemia: Relation to Cephalosporin Side Chain, Vitamin K Metabolism, and Vitamin K Status (1988) (114)
Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies. (2015) (114)
Diabetic nephropathy in type 2 diabetes prevention and patient management. (2003) (113)
Wegener's granulomatosis with renal involvement: patient survival and correlations between initial renal function, renal histology, therapy and renal outcome. (1991) (113)
Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease. (2012) (113)
Cardiac remodelling in experimental renal failure--an immunohistochemical study. (1998) (112)
Glycemic Control and Cardiovascular Events in Diabetic Hemodialysis Patients (2009) (112)
Clinical manifestation and natural history of diabetic nephropathy. (2011) (112)
Retinoic acid reduces glomerular injury in a rat model of glomerular damage. (2000) (110)
Hemostasis and thromboembolism in children with nephrotic syndrome: differences from adults. (1987) (110)
Demonstration of 1,25(OH)2 vitamin D3 receptors and actions in vascular smooth muscle cellsIn vitro (1987) (108)
Recombinant human erythropoietin therapy in haemodialysis patients--dose determination and clinical experience. (1987) (108)
The rising tide of endstage renal failure from diabetic nephropathy type II--an epidemiological analysis. (1995) (108)
Nephropathy in type 2 diabetes (1999) (107)
Aortic changes in experimental renal failure: hyperplasia or hypertrophy of smooth muscle cells? (1997) (107)
Myocardial hypertrophy in rats with renal insufficiency. (1985) (106)
Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uraemia? (2000) (105)
Symmetrical and asymmetrical dimethylarginine as predictors for mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study. (2011) (105)
Evidence for Impaired Hepatic Vitamin K1 Metabolism in Patients Treated with N-Methyl-Thiotetrazole Cephalosporins (1984) (105)
Preventing microalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study (2006) (104)
How should we manage anaemia in patients with diabetes? (2002) (104)
A polymorphism in the gene for the angiotensin II type 1 receptor is not associated with hypertension (1997) (104)
Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humans. (1997) (103)
Special characteristics of atherosclerosis in chronic renal failure. (2003) (102)
Apolipoprotein A, fibrinogen, age, and history of stroke are predictors of death in dialysed diabetic patients: a prospective study in 412 subjects. (1997) (101)
Glomerulosclerosis and progression: Effect of subantihypertensive doses of α and βblockers (2001) (101)
Beneficial Effects of Estrogens on Indices of Renal Damage in Uninephrectomized SHRsp Rats. (2004) (101)
Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis (1999) (100)
Cuprammonium membranes stimulate interleukin 1 release and arachidonic acid metabolism in monocytes in the absence of complement. (1988) (100)
Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study. (2012) (100)
Malignancy after renal transplantation. (2002) (99)
Vitamin D status and mortality in chronic kidney disease. (2011) (98)
Morbidity and mortality due to hypertension in patients with renal failure. (1993) (98)
Skeletal abnormalities in chronic renal insufficiency before and during maintenance hemodialysis. (1973) (97)
Hyperphosphataemia--a silent killer of patients with renal failure? (1999) (97)
No 1,25-dihydroxyvitamin D3 receptors on osteoclasts of calcium-deficient chicken despite demonstrable receptors on circulating monocytes. (1986) (96)
Diminished vascular response to noradrenaline in experimental chronic uremia. (1982) (95)
Left ventricular hypertrophy in renal failure. (1998) (95)
Elevated blood pressure profile and left ventricular mass in children and young adults with autosomal dominant polycystic kidney disease. (1993) (95)
Abnormal bone histology in idiopathic hypercalciuria. (1980) (94)
Presence of a 1,25-dihydroxy-vitamin D3 receptor in chick skeletal muscle myoblasts. (1985) (93)
Low homoarginine concentration is a novel risk factor for heart disease (2011) (93)
Podocytes are the major source of IL-1α and IL-1β in human glomerulonephritides (1997) (93)
Effect of ramipril, nifedipine, and moxonidine on glomerular morphology and podocyte structure in experimental renal failure. (1996) (93)
Increased infarct size in uremic rats: reduced ischemia tolerance? (2004) (92)
Serum lipids predict cardiac death in diabetic patients on maintenance hemodialysis. Results of a prospective study. The German Study Group Diabetes and Uremia. (1993) (92)
IMPROVED SEXUAL FUNCTION IN MALE HÆMODIALYSIS PATIENTS ON BROMOCRIPTINE (1979) (91)
Albuminuria in normotensive and hypertensive individuals attending offices of general practitioners (1996) (91)
The renal risks of smoking: an update (2002) (90)
Slipped epiphyses in renal osteodystrophy. (1975) (90)
Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis. (2007) (89)
Multicystic transformation of kidneys in chronic renal failure. (1984) (88)
A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia. (2009) (88)
Expression of receptors for advanced glycosylated end-products in renal disease. (1995) (88)
Late referral--a major cause of poor outcome in the very elderly dialysis patient. (2006) (88)
Vitamin D and problems related to uremic bone disease. (1975) (87)
Apolipoprotein A-IV predicts progression of chronic kidney disease: the mild to moderate kidney disease study. (2006) (86)
Association of M235T variant of the angiotensinogen gene with familial hypertension of early onset. (1995) (86)
Adult dominant polycystic kidney disease--clinical problems. (1988) (85)
Ethylene oxide (ETO) as a major cause of anaphylactoid reactions in dialysis (a review). (1987) (85)
Aldosterone and arterial hypertension (2010) (84)
Apolipoprotein A-IV serum concentrations are elevated in patients with mild and moderate renal failure. (2002) (84)
Smoking: a factor promoting onset and progression of diabetic nephropathy. (2000) (84)
G protein beta3 subunit 825T allele and its potential association with obesity in hypertensive individuals. (1999) (83)
In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. (1993) (83)
Renal handling of drugs in the healthy elderly Creatinine clearance underestimates renal function and pharmacokinetics remain virtually unchanged (1999) (82)
Comparison of renal morphology in the Streptozotocin and the SHR/N-cp models of diabetes (2004) (82)
Low-dose calcitriol prevents the rise in 1,84-iPTH without affecting serum calcium and phosphate in patients with moderate renal failure (prospective placebo-controlled multicentre trial). (1995) (82)
Albuminuria and vascular damage--the vicious twins. (2003) (82)
Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus. (2005) (82)
Both high and low maternal salt intake in pregnancy alter kidney development in the offspring. (2011) (82)
Microvascular disease--the Cinderella of uraemic heart disease. (2000) (81)
Rapidly progressive glomerulonephritis: analysis of prevalence and clinical course. (1991) (80)
How frequent is glomerulonephritis in diabetes mellitus type II? (1992) (80)
Metabolic clearance of recombinant human growth hormone in health and chronic renal failure. (1994) (79)
Pathogenesis of clinical hyponatremia: observations of vasopressin and fluid intake in 100 hyponatremic medical patients (1987) (78)
Doppler echocardiographic findings in dialysis patients. (1990) (77)
Pro-A-type natriuretic peptide and pro-adrenomedullin predict progression of chronic kidney disease: the MMKD Study. (2009) (77)
Target level for hemoglobin correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) Study. (2007) (76)
Calcification and cardiovascular problems in renal failure. (2005) (76)
Salt and its effect on blood pressure and target organ damage: new pieces in an old puzzle. (2009) (75)
Control of pulsatile and tonic parathyroid hormone secretion by ionized calcium. (1996) (75)
Acquired renal cysts in uremic patients--in vivo demonstration by computed tomography. (1980) (72)
Alanine to serine polymorphism at position 986 of the calcium-sensing receptor associated with coronary heart disease, myocardial infarction, all-cause, and cardiovascular mortality. (2007) (72)
Beta-thromboglobulin is elevated in renal failure without thrombosis. (1980) (72)
Why patients with progressing kidney disease are referred late to the nephrologist: on causes and proposals for improvement. (2005) (72)
The acute effect of growth hormone on GFR is obliterated in chronic renal failure. (1989) (72)
Retinoids Inhibit the Actions of Angiotensin II on Vascular Smooth Muscle Cells (2001) (71)
Multifactorial control of the elimination kinetics of unbound (free) growth hormone (GH) in the human: regulation by age, adiposity, renal function, and steady state concentrations of GH in plasma. (1996) (71)
Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients (2011) (71)
Left ventricular hypertrophy in renal disease: beyond preload and afterload. (2009) (71)
Prenatal programming—effects on blood pressure and renal function (2011) (70)
Cardiac changes in uraemia and their possible relationship to cardiovascular instability on dialysis. (1990) (70)
Arterial calcification in patients with chronic kidney disease. (2009) (70)
Glomerulosclerosis and progression: effect of subantihypertensive doses of alpha and beta blockers. (2001) (70)
Nephropathy of type II diabetes: evidence for hereditary factors? (1997) (70)
Comparison of intermittent and continuous oral administration of calcitriol in dialysis patients: a randomized prospective trial. (1994) (69)
Angiotensin formation in the isolated rat hindlimb. (1989) (69)
Complement components as uremic toxins and their potential role as mediators of microinflammation. (2001) (69)
Treatment of secondary hyperparathyroidism in CKD patients with cinacalcet and/or vitamin D derivatives. (2009) (68)
Acute blood pressure effects and chronic hypotensive action of calcimimetics in uremic rats. (2006) (68)
Toxicity of uraemia--does it come of AGE? (1994) (68)
Angiotensin II receptor type 1 gene expression in human glomerulonephritis and diabetes mellitus. (1999) (68)
Renal endothelin-1 and endothelin receptor type B expression in glomerular diseases with proteinuria. (2001) (68)
Effects of vitamin D and parathyroid hormone on muscle: potential role in uremic myopathy. (1980) (67)
Intermittent versus continuous administration of 1,25-dihydroxyvitamin D3 in experimental renal hyperparathyroidism. (1993) (67)
Salt – A Potential ‘Uremic Toxin’? (2005) (67)
Cigarette smoke condensate aggravates renal injury in the renal ablation model. (2002) (66)
Capillary/myocyte mismatch in the heart in renal failure--a role for erythropoietin? (2000) (66)
Retinoid receptor-specific agonists alleviate experimental glomerulonephritis. (2002) (65)
Atherogenesis and cardiac death: are they related to dialysis procedure and biocompatibility? (1994) (65)
The effect of enalapril on glomerular growth and glomerular lesions after subtotal nephrectomy in the rat: a stereological analysis (1993) (65)
Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure. (1996) (65)
Stabilized polynuclear iron hydroxide is an efficient oral phosphate binder in uraemic patients. (1999) (64)
Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus. (2009) (64)
Skeletal growth in experimental uremia. (1983) (64)
Vascular calcification--is aldosterone a culprit? (2013) (64)
The ET(A) receptor blocker LU 135252 prevents chronic transplant nephropathy in the "Fisher to Lewis" model. (1999) (64)
Cardiomyocyte loss in experimental renal failure: prevention by ramipril. (2003) (63)
Audit of antihypertensive treatment in patients with renal failure. (1998) (63)
Amyloid kidney stone of uremic patients consist of Beta2-microglobulin fragments (1986) (63)
The message for World Kidney Day 2009: Hypertension and kidney disease: A marriage that should be prevented (2009) (63)
Low Serum Homoarginine Is a Novel Risk Factor for Fatal Strokes in Patients Undergoing Coronary Angiography (2011) (63)
Do AV Fistulas Contribute to Cardiac Mortality in Hemodialysis Patients? (2002) (63)
Sympathetic overactivity and arterial hypertension in renal failure. (2001) (63)
Growth in renal failure. (1978) (62)
Angiotensin-Converting Enzyme Inhibitors and Kidney Protection: The AIPRI Trial (1999) (62)
Silicone-induced splenomegaly: treatment of pancytopenia by splenectomy in a patient on hemodialysis. (1981) (62)
Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. (1992) (62)
Intestinal-Renal Syndrome: Mirage or Reality? (2011) (62)
No evidence for endotoxin transfer across high flux polysulfone membranes. (1987) (62)
Efficacy comparison of intravenous and subcutaneous recombinant human erythropoietin administration in hemodialysis patients. (1991) (60)
Associations of plasma renin with 10-year cardiovascular mortality, sudden cardiac death, and death due to heart failure. (2011) (60)
Kidney and hypertension. (2002) (60)
Effects of retinoids on the TGF-beta system and extracellular matrix in experimental glomerulonephritis. (2001) (60)
Long-term progression of chronic renal insufficiency in the AIPRI Extension Study. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. (1997) (60)
Urinary matrix calculi consisting of microfibrillar protein in patients on maintenance hemodialysis. (1979) (60)
Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. (1999) (60)
Determinants of plasma beta 2 microglobulin concentration: possible relation to membrane biocompatibility. (1987) (60)
ANAPHYLACTOID REACTIONS IN DIALYSIS PATIENTS: ROLE OF ETHYLENE-OXIDE (1985) (59)
Excess of DD homozygotes in haemodialysed patients with type II diabetes. The Diabetic Nephropathy Study Group. (1997) (59)
Effect of 1,25-dihydroxycholecalciferol on impaired calcium transport by the sarcoplasmic reticulum in experimental uremia. (1977) (59)
Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study (2009) (59)
Influence of specific and non-specific endothelin receptor antagonists on renal morphology in rats with surgical renal ablation. (1996) (59)
Is vasculitis in subacute bacterial endocarditis associated with ANCA? (1991) (58)
Endothelin A receptor blockade prevents capillary/myocyte mismatch in the heart of uremic animals. (2000) (58)
Is there an obesity–metabolic syndrome related glomerulopathy? (2011) (58)
Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature. (2004) (58)
Altered instantaneous and calcium-modulated oscillatory PTH secretion patterns in patients with secondary hyperparathyroidism. (1998) (58)
Calcitriol ameliorates capillary deficit and fibrosis of the heart in subtotally nephrectomized rats. (2008) (58)
Podocytes are the major source of IL-1 alpha and IL-1 beta in human glomerulonephritides. (1997) (57)
Lipid changes and statins in chronic renal insufficiency. (2006) (57)
Heart and kidney: fatal twins? (2006) (57)
Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. The Peritoneal Dialysis Multicenter Study Group. (1995) (56)
Synergistic effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on proliferation and vitamin D receptor expression of rat growth cartilage cells. (1994) (56)
Retinoic acid receptor α and retinoid X receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the rat (2004) (56)
Natriuresis-pressure relationship in polycystic kidney disease. (1990) (56)
Survival on renal replacement therapy in Europe: is there a 'centre effect'? (1996) (56)
Improved sexual function during recombinant human erythropoietin therapy. (1990) (55)
Prevention of p.o. clotting of av. cimino fistulae with Acetylsalicyl acid results of a prospective double blind study (1974) (54)
Hyperparathyroidism in chronic renal failure and dialysis osteodystrophy. (1970) (54)
Postinfectious glomerulonephritis--is there a link to alcoholism? (1994) (54)
The Urinary Sediment: An Integrated View (1998) (54)
Renal function in the elderly--is the dogma of an inexorable decline of renal function correct? (1997) (54)
Aldosterone/renin ratio determines peripheral and central blood pressure values over a broad range. (2010) (54)
National Kidney Foundation consensus conference on cardiovascular and kidney diseases and diabetes risk: an integrated therapeutic approach to reduce events. (2010) (54)
The effect of dietary salt on insulin sensitivity (1995) (53)
Rats with moderate renal failure show capillary deficit in heart but not skeletal muscle. (1997) (53)
Tamm Horsfall glycoprotein interferes with bacterial adherence to human kidney cells (1988) (53)
Effects of rhGH and rhIGF-1 on renal growth and morphology. (1993) (53)
Hyperlipoproteinemia in renal insufficiency. (1980) (52)
Dialysis hypotension--is it related to diastolic left ventricular malfunction? (1987) (52)
Hypertension in the Transplanted Patient (1998) (52)
Relationship between plasma aldosterone concentration and soluble cellular adhesion molecules in patients referred to coronary angiography. (2011) (52)
Nuclear testicular 1,25-dihydroxyvitamin D3 receptors in Sertoli cells and seminiferous tubules of adult rodents. (1985) (52)
Blood pressure and metabolic control as risk factors for nephropathy in Type 1 (insulin-dependent) diabetes (2004) (52)
Immunohistochemical detection of 1,25-dihydroxyvitamin D3 receptors and estrogen receptors by monoclonal antibodies: comparison of four immunoperoxidase methods. (1989) (52)
Nephroprotection of an ETA-Receptor Blocker (LU 135252) in Salt-Loaded Uninephrectomized Stroke-Prone Spontaneously Hypertensive Rats (1998) (51)
The diabetic foot in the dialyzed patient. (2000) (51)
The Normal Haematocrit Trial in dialysis patients with cardiac disease: are we any the less confused about target haemoglobin? (1998) (51)
Effects of all-trans retinoic acid on renin-angiotensin system in rats with experimental nephritis. (2001) (51)
Effect of antioxidant therapy with dl-alpha-tocopherol on cardiovascular structure in experimental renal failure. (2002) (51)
PENICILLIN-INDUCED COAGULATION DISORDER (1976) (51)
Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patients (2012) (50)
Inhibitory effect of calcium channel blockers on human mesangial cell growth: evidence for actions independent of L-type Ca2+ channels. (1996) (50)
Blood pressure-independent additive effects of pharmacologic blockade of the renin-angiotensin and endothelin systems on progression in a low-renin model of renal damage. (2001) (50)
Minor renal dysfunction: an emerging independent cardiovascular risk factor (2003) (50)
Renal Damage in the SHR/N-cp Type 2 Diabetes Model: Comparison of an Angiotensin-Converting Enzyme Inhibitor and Endothelin Receptor Blocker (2003) (50)
Water quality--a neglected problem in hemodialysis. (1987) (50)
Calcimimetic R-568 or calcitriol: equally beneficial on progression of renal damage in subtotally nephrectomized rats. (2008) (50)
Does low urinary sIgA predispose to urinary tract infection? (1983) (50)
Adverse effects of smoking in the renal patient. (2001) (49)
Proteinuria after renal transplantation: pathogenesis and management. (2004) (49)
Uremia as a cause of bleeding. (1985) (49)
Salt intake in kidney disease--a missed therapeutic opportunity? (2012) (49)
Renal hemodynamics in recent-onset type II diabetes. (1992) (49)
Urinary sIgA in children with urinary tract infection. (1986) (49)
Lipid abnormalities and cardiovascular risk in renal disease. (2008) (48)
Use of angiotensin-converting enzyme inhibitors for the preservation of kidney function. A retrospective study. (1990) (48)
Endothelin receptor antagonists influence cardiovascular morphology in uremic rats. (1999) (48)
Why is coronary heart disease of uraemic patients so frequent and so devastating? (2003) (48)
Genetics of the renin‐angiotensin system and renal disease: a progress report (1997) (48)
Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy. The Diabetic Nephropathy Study Group. (1996) (47)
Metabolic clearance of recombinant human growth hormone in health and chronic renal failure (1995) (47)
Relation of mesangial IgA glomerulonephritis to polymorphism of immunoglobulin heavy chain switch region. (1988) (46)
Genetic polymorphism of C3 and Bf in IgA nephropathy. (1987) (46)
Demonstration and characterisation of a testicular receptor for 1,25-dihydroxycholecalciferol in the rat. (1983) (46)
Local angiotensin formation in hindlimbs of uremic hypertensive and renovascular hypertensive rats (1991) (46)
In situ upregulation of IL-10 reflects the activity of human glomerulonephritides. (1998) (46)
The effect of malnutrition on cardiovascular mortality in dialysis patients: is L-arginine the answer? (1994) (46)
Association of relative telomere length with progression of chronic kidney disease in two cohorts: effect modification by smoking and diabetes (2015) (46)
The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented. (2009) (46)
Metabolic Syndrome and Kidney Disease (2008) (46)
Cardiovascular mortality of patients with polycystic kidney disease on dialysis: is there a lesson to learn? (1994) (46)
ATP release in human kidney cortex and its mitogenic effects in visceral glomerular epithelial cells. (2002) (46)
Intraperitoneal protein injection in the axolotl: the amphibian kidney as a novel model to study tubulointerstitial activation. (2002) (45)
Chronic hypokalaemia of adults: Gitelman's syndrome is frequent but classical Bartter's syndrome is rare. (1995) (45)
Disturbed calcium metabolism in renal failure--pathogenesis and therapeutic strategies. (1992) (45)
Catheter-based renal sympathetic denervation for resistant hypertension : A multicenter safety and proof-of-principle cohort study (2009) (45)
NON‐CORONARY HEART DISEASE IN DIALYSIS PATIENTS: Sympathetic Overactivity—The Cinderella of Cardiovascular Risk Factors in Dialysis Patients (2008) (45)
Hyperlipoproteinemia in experimental chronic renal insufficiency in the rat. (1978) (45)
NON‐CORONARY HEART DISEASE IN DIALYSIS PATIENTS: Cardiac Problems in the Dialysis Patient: Beyond Coronary Disease (2008) (45)
The simple renal cyst. (2000) (45)
Stimulation of beta 2-microglobulin synthesis in lymphocytes after exposure to Cuprophan dialyzer membranes. (1991) (45)
Angiotensin II enhances insulin sensitivity in healthy volunteers under euglycemic conditions (1993) (45)
Effect of paricalcitol and calcitriol on aortic wall remodeling in uninephrectomized ApoE knockout mice. (2011) (45)
Scleroderma renal crisis as a presenting feature in the absence of skin involvement. (1993) (45)
Skeletal X-ray findings and bone histology in patients on hemodialysis. (1978) (45)
Effects of long-term infusion of physiologic doses of 1-34 PTH on bone. (1982) (45)
Differential regulation of transforming growth factor receptors by angiotensin II and transforming growth factor-β1 in vascular smooth muscle (1999) (44)
HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients. (2015) (44)
Interaction of IGF-I and 1 alpha, 25(OH)2D3 on receptor expression and growth stimulation in rat growth plate chondrocytes. (1998) (44)
Hypercoagulability in the nephrotic syndrome (1980) (43)
Role of sodium intake in the progression of chronic kidney disease. (2009) (43)
Cardiovascular problems on hemodialysis: current deficits and potential improvement. (2009) (43)
Angiotensin II induces hypertrophy and hyperplasia in adult human mesangial cells. (1995) (43)
Hyperparathyroidism and abnormal calcitriol metabolism in the spontaneously hypertensive rat. (1989) (43)
Functional, biochemical, and molecular investigations of renal kallikrein-kinin system in diabetic rats. (1999) (43)
Strict glycaemic control in diabetic patients with CKD or ESRD: beneficial or deadly? (2010) (43)
Vitamin D and cancer mortality: systematic review of prospective epidemiological studies. (2013) (43)
Loss of bone resulting from accumulation of aluminum in bone of patients undergoing dialysis. (1986) (43)
Association of plasma aldosterone with cardiovascular mortality in patients with low estimated GFR: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. (2011) (43)
Some cardiac abnormalities in renal failure. (1997) (43)
The message for World Kidney Day 2009: Hypertension and kidney disease: a marriage that should be prevented. (2009) (43)
The drama of the continuous increase in end-stage renal failure in patients with type II diabetes mellitus. (1998) (42)
Immunological determination of advanced glycosylation end-products in human blood and urine. (1995) (42)
Glycated and carbamylated albumin are more "nephrotoxic" than unmodified albumin in the amphibian kidney. (2011) (42)
The role of surface charge on the accelerating action of heparin on the antithrombin III-inhibited activity of alpha-thrombin. (1985) (42)
The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) Observational Follow‐Up Study: Benefits of RAS Blockade With Olmesartan Treatment Are Sustained After Study Discontinuation (2014) (41)
The spectrum of renal involvement in epidermolysis bullosa dystrophica hereditaria: report of two cases. (1988) (41)
RECOMBINANT HUMAN ERYTHROPOIETIN IN ANAEMIC PATIENTS ON HAEMODIALYSIS (1987) (41)
Renal disease in type 2 diabetes. (2001) (41)
Remodeling of resistance arteries in renal failure: effect of endothelin receptor blockade. (2001) (41)
Diabetic nephropathy and anaemia (2005) (41)
Thirst and the renin-angiotensin system. (1987) (41)
Angiotensin I converting enzyme gene polymorphism and diabetic nephropathy in type II diabetes. (1997) (41)
Hypertension and antihypertensive treatment of diabetic nephropathy (2006) (41)
The association between parathyroid hormone and mortality in dialysis patients is modified by wasting (2009) (40)
Nephrologists neglect administration of betablockers to dialysed diabetic patients. (1997) (40)
Homoarginine and Progression of Chronic Kidney Disease: Results from the Mild to Moderate Kidney Disease Study (2013) (40)
Effects of parathyroidectomy on blood pressure in spontaneously hypertensive rats. (1987) (40)
The pathogenesis of secondary hyperparathyroidism of renal failure. Is there a controversy? (1978) (40)
Impact of Aldosterone on Osteoinductive Signaling and Vascular Calcification (2014) (40)
The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials (2016) (40)
Dialysis membranes and coagulation system. (1986) (39)
Relationship between Hypertension and Renal Function and Its Therapeutic Implications in the Elderly (1998) (39)
Isotretinoin alleviates renal damage in rat chronic glomerulonephritis. (2001) (39)
The role of the parathyroid glands in the uremic syndrome. (1995) (39)
Why are lipids not predictive of cardiovascular death in the dialysis patient? (1996) (39)
Acute renal failure, hypertension and skin necrosis in a patient with streptokinase therapy. (1984) (39)
Type II diabetes mellitus: is the renal risk adequately appreciated? (1991) (39)
G protein beta3 subunit 825T allele and hypertension. (1999) (39)
Increased prevalence of salt sensitivity of blood pressure in IDDM with and without microalbuminuria (1995) (39)
High salt intake causes adverse fetal programming--vascular effects beyond blood pressure. (2012) (38)
The Selective Vitamin D Receptor Activator for Albuminuria Lowering (VITAL) Study: Study Design and Baseline Characteristics (2009) (38)
Initiation of dialysis-opinions from an international survey: Report on the Dialysis Opinion Symposium at the ERA-EDTA Congress, 18 September 2000, Nice. (2001) (38)
Rapidly progressive IgA nephropathy with anti-myeloperoxidase antibodies benefits from immunosuppression. (1997) (38)
Management of disturbed calcium metabolism in uraemic patients: 2. Indications for parathyroidectomy. (2000) (38)
Skeletal changes and growth in experimental uremia. (1977) (38)
Pathophysiology of hypertensive renal damage. (1993) (38)
Pathogenesis and course of renal disease in IDDM/NIDDM: differences and similarities. (1997) (38)
Frequency of albuminuria in primary care: a cross-sectional study (2007) (38)
Congestive Heart Failure Due to Systolic Dysfunction: The Cinderella of Cardiovascular Management in Dialysis Patients (2002) (37)
Failure of arginine-vasopressin and other pressor hormones to increase in severe recurrent dialysis hypotension. (1995) (37)
Angiotensin-converting enzyme inhibitors and kidney protection: the AIPRI trial. The ACE Inhibition in Progressive Renal Insufficiency (AIPRI) Study Group. (1999) (37)
Anticipation of age at renal death in autosomal dominant polycystic kidney disease (ADPKD)? (1995) (37)
PDGF and TGF-beta contribute to the natural course of human IgA glomerulonephritis. (1995) (37)
Total cardiovascular risk management. (2007) (37)
Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis. Die Deutsche Diabetes Dialyse Studie Investigators. (1999) (37)
Blood pressure in minimal change and other types of nephrotic syndrome. (1990) (37)
Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL study (2013) (37)
Dyslipidemia in chronic kidney disease (2012) (37)
Chronic kidney disease: why is current management uncoordinated and suboptimal? (2001) (37)
Clinical features and natural history of IgA nephropathy. (1999) (37)
Regression of glomerulosclerosis in subtotally nephrectomized rats: effects of monotherapy with losartan, spironolactone, and their combination. (2008) (36)
Hypertension after renal transplantation (2001) (36)
Is intermittent oral calcitriol safe and effective in renal secondary hyperparathyroidism? (1991) (36)
Antibody coating of urinary bacteria: relation to site of infection and invasion of uroepithelium. (1978) (36)
Plasma thrombomodulin: a marker for microvascular complications in diabetes mellitus. (1996) (36)
The influence of immobilization on osteocyte morphology (1976) (36)
ACE-inhibition is superior to endothelin A receptor blockade in preventing abnormal capillary supply and fibrosis of the heart in experimental diabetes (2004) (35)
[Incidence and clinical characteristics of renal insufficiency in diabetic patients]. (2001) (35)
Detection and clinical implication of anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis and rapidly progressive glomerulonephritis. (1989) (35)
Metabolic bone disease in patients on maintenance hemodialysis. (1974) (35)
Beneficial effect of nifedipine and moxonidine on glomerulosclerosis in spontaneously hypertensive rats. A micromorphometric study. (1992) (35)
Interstitial fibrosis and microvascular disease of the heart in uremia: amelioration by a calcimimetic (2009) (35)
High-Dose Enalapril Treatment Reverses Myocardial Fibrosis in Experimental Uremic Cardiomyopathy (2011) (35)
Effects of testosterone on glomerular growth after uninephrectomy. (1998) (35)
Hypertrophy of intramyocardial arteriolar smooth muscle cells in experimental renal failure. (1999) (34)
Plastic filing from dialysis tubing induces prostanoid release from macrophages. (1984) (34)
A polymorphism in the gene for the endothelial nitric oxide synthase and diabetic nephropathy. (2001) (34)
Phosphate: a novel cardiovascular risk factor. (2013) (34)
Diabetic nephropathy: recent insights into the pathophysiology and the progression of diabetic nephropathy. (2005) (34)
Stimulation of mononuclear cells by contact with cuprophan membranes: further increase of beta 2-microglobulin synthesis by activated late complement components. (1993) (34)
Should hyperlipemia of renal failure be treated? (1985) (34)
Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rate. (2001) (34)
Urinary lead excretion in uremic patients. (1986) (34)
Genetic abnormalities in parathyroid nodules of uremic patients. (1998) (34)
Renal protection in diabetes: lessons from ONTARGET® (2010) (34)
Phosphate binders on iron basis: a new perspective? (1999) (33)
Increased frequency of G-protein beta 3-subunit 825 T allele in dialyzed patients with type 2 diabetes. (1999) (33)
Renoprotective effect of a dopamine D3 receptor antagonist in experimental type II diabetes (2006) (33)
Cardiac changes in uremia and their possible relation to cardiovascular instability on dialysis. (1990) (33)
Protocol biopsy: what is the rationale and what is the evidence? (2003) (33)
Managing mineral balance in end-stage renal disease. (2004) (33)
Dosing angiotensin II blockers--beyond blood pressure. (1999) (33)
Letter: Life on haemodialysis. (1975) (33)
Effect of vitamin D on growth in experimental uremia. (1978) (33)
Angiotensin II affects basal, pulsatile, and glucose-stimulated insulin secretion in humans. (1997) (33)
ANCA in haemodialysis patients. (1993) (33)
Prevention of microalbuminuria in patients with type 2 diabetes and hypertension (2012) (33)
Lifestyle modification and progressive renal failure (2005) (32)
Renal cell carcinoma in dialysis patients with acquired renal cysts. (1989) (32)
The renoprotective effect of angiotensin-converting enzyme inhibitors in experimental chronic renal failure is not dependent on enhanced kinin activity. (1998) (32)
Salt restriction in kidney disease—a missed therapeutic opportunity? (2009) (32)
Cardiovascular complications in the diabetic patient with renal disease: an update in 2003. (2003) (32)
Role of phosphate in the genesis of secondary hyperparathyroidism of renal failure. (1977) (32)
Renal cystic disease (ADPKD and ARPKD). (2002) (32)
Effects of ACE inhibition and bradykinin antagonism on cardiovascular changes in uremic rats. (2000) (32)
Actions of 1,25-dihydroxyvitamin D3 on human mesangial cells. (1991) (32)
Intestinal cholesterol absorption, treatment with atorvastatin, and cardiovascular risk in hemodialysis patients. (2015) (32)
Phosphate binders in uraemia: pharmacodynamics, pharmacoeconomics, pharmacoethics. (2002) (32)
Angiotensin II and oxidative stress: an unholy alliance. (2003) (31)
Myocardial interstitial fibrosis in uraemia: is it relevant? (1994) (31)
Amyloid kidney stones of uremic patients consist of beta 2-microglobulin fragments. (1986) (31)
To prevent progression: ACE inhibitors, calcium antagonists or both? (1995) (31)
Different effects of renal failure on beta-thromboglobulin and high affinity platelet factor 4 (HA-PF4)-concentrations. (1980) (31)
Angiotensin II Affects Basal, Pulsatile, and Glucose-Stimulated Insulin Secretion in Humans (1997) (31)
Wasting and sudden cardiac death in hemodialysis patients: a post hoc analysis of 4D (Die Deutsche Diabetes Dialyse Studie). (2011) (31)
The sympathetic nervous system and the kidney: its importance in renal diseases. (1998) (31)
Vascular effects of parathyroid hormone (PTH). (1982) (31)
Systemic Inflammation Precedes Microalbuminuria in Diabetes (2019) (31)
Diabetic nephropathy – Epidemiology in Asia and the current state of treatment (2011) (31)
A 63bp deletion in the promoter of rage correlates with a decreased risk for nephropathy in patients with type 2 diabetes. (2004) (31)
SILICONE CELL INCLUSIONS CAUSING MULTI-ORGAN FOREIGN BODY REACTION IN DIALYSED PATIENTS (1981) (31)
Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites. (2000) (31)
Morphological studies on pathogenesis of epiphyseal slipping in uremic children (1974) (31)
Survival on renal replacement therapy in Europe: is there a ‘centre effect’? (1996) (31)
No decrease of 1,25(OH)2D3 receptors and duodenal calbindin‐D9k in uraemic rats (1991) (31)
Changes in the kinetics and biopotency of luteinizing hormone in hemodialyzed men during treatment with recombinant human erythropoietin. (1994) (31)
Advanced glycation endproducts (AGEs) as uremic toxins. (2001) (30)
Strategies to decrease cardiovascular mortality in patients with end-stage renal disease. (2002) (30)
Sexual behaviour of hemodialyzed patients. (1976) (30)
Calcium, calcium regulatory hormones, and calcimimetics: impact on cardiovascular mortality. (2006) (30)
Cardiovascular abnormalities in ageing and in uraemia--only analogy or shared pathomechanisms? (1998) (30)
Silicone storage disease in long-term hemodialysis patients. (1983) (30)
The in situ expression of interleukin-8 in the normal human kidney and in different morphological forms of glomerulonephritis. (2004) (30)
Hyperlipidemia and obesity after renal transplantation. (2001) (30)
The Microinflammatory State of Uremia (2000) (30)
[Diabetic nephropathy in type II diabetes: effect of metabolic control and blood pressure on its development and course]. (2008) (30)
Frusemide therapy and intact parathyroid hormone plasma concentrations in chronic renal insufficiency. (1992) (30)
Role of calcium-phosphorous disorders in the progression of renal failure. (2005) (30)
Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120 (2017) (29)
Increased genetic risk of hypertension in glomerulonephritis? (1990) (29)
Role of diuretics, hormonal derangements, and clinical setting of hyponatremia in medical patients (1988) (29)
Reduced chronotropic responsiveness of the heart in experimental uremia. (1986) (29)
Direct arteriovenous fistula for hemodialysis. (1968) (29)
Graves' disease and sarcoidosis in a patient with minimal-change glomerulonephritis. (1996) (29)
Hvpoprothrombinemia caused by cephalosporins (1985) (29)
Homoarginine, kidney function and cardiovascular mortality risk. (2014) (29)
Changes in plasma phosphate levels influence insulin sensitivity under euglycemic conditions. (1996) (29)
Effects of Hormones Other than Parathyroid Hormones on Renal Handling of Phosphate (1980) (29)
The genetics of renal tumors in end-stage renal failure differs from those occurring in the general population. (1998) (29)
Opposing effects of angiotensin II on muscle and renal blood flow under euglycemic conditions. (2000) (28)
Limitations and Future Treatment Options in Type 2 Diabetes With Renal Impairment (2011) (28)
Altered temporal organization of plasma insulin oscillations in chronic renal failure. (2002) (28)
The history of salt - aspects of interest to the nephrologist. (1996) (28)
Immunogenetic findings in glomerulonephritis. (1993) (28)
Protein restriction in the conservative management of uremia. (1978) (28)
Long Term Dialysis with Low-Calcium Solution (1.0 Mmol/L) in Capd: Effects on Bone Mineral Metabolism (1996) (28)
Renal angioplasty for lowering blood pressure. (2000) (28)
Hypertension and left ventricular hypertrophy in the CAPD patient. (1996) (28)
Interaction of the G protein beta 3 subunit T825 allele and the IRS-1 Arg972 variant in type 2 diabetes. (2000) (28)
Homeostasis of Phosphate and Other Minerals (1978) (28)
Comparing outcomes in renal replacement therapy: how should we correct for case mix? (1998) (28)
Systemic hypersensitivity to allopurinol with acute interstitial nephritis. (1981) (28)
Phosphate and Minerals in Health and Disease (1980) (28)
Which is the preferred treatment of advanced hyperparathyroidism in a renal patient? II. Early parathyroidectomy should be considered as the first choice. (1994) (27)
Angiotensin-converting enzyme inhibitors may cause renal dysfunction in patients on long-term lithium treatment. (1995) (27)
Alcohol and kidney damage: a Janus-faced relationship. (2012) (27)
Retinoid agonist isotretinoin ameliorates obstructive renal injury. (2003) (27)
Bioincompatibility--perspectives in 1993. (1994) (27)
Angiotensin converting enzyme inhibitors, calcium channel blockers, and their combination in the treatment of glomerular disease. (1997) (27)
Chronic hemofiltration. A critical evaluation of a new method for the treatment of blood. (2008) (27)
Renal dysfunction as a novel risk factor: microalbuminuria and cardiovascular risk. (2005) (27)
Antibody-coated bacteria in the ejaculate: a possible test for prostatitis. (1977) (27)
Managing anaemia and diabetes: a future challenge for nephrologists. (2005) (27)
Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial (2012) (27)
Natural History of Nephropathy in Type I Diabetes: Relationship to Metabolic Control and Blood Pressure (1985) (27)
HYDRA: possible determinants of unsatisfactory hypertension control in German primary care patients (2004) (27)
Receptors for advance glycation end-products (AGE) - expression by endothelial cells in non-diabetic uraemic patients. (1996) (27)
The Heart in Renal Failure: Morphological Changes of the Myocardium - New Insights (2001) (27)
More adverse renal prognosis of autosomal dominant polycystic kidney disease in families with primary hypertension. (1995) (27)
Sulfur-containing amino acids are a major determinant of urinary calcium. (1985) (27)
Nephroprotection of an ET(A)-receptor blocker (LU 135252) in salt-loaded uninephrectomized stroke-prone spontaneously hypertensive rats. (1998) (27)
Increased renoprotection with ACE inhibitor plus aldosterone antagonist as compared to monotherapies--the effect on podocytes. (2009) (27)
Haemodynamic effects of intact digoxin antibody and its Fab fragments in experimental hypertension. (1987) (26)
Necrotizing dermatitis resulting from hemodialysis with polyvinylchloride tubing. (1979) (26)
How can we improve prognosis in diabetic patients with end-stage renal disease? (1999) (26)
Chronic lead exposure in rats: effects on blood pressure (1993) (26)
Renal osteodystrophy in children on maintenance haemodialysis. (1973) (26)
Beta1-adrenergic blockade augments pulsatile PTH secretion in humans. (2003) (26)
Expression of receptors for advanced glycation end-products in occlusive vascular and renal disease. (1996) (26)
Salt--friend or foe? (2006) (26)
Proteinuria and hypertension. (1994) (26)
The Combination of ACE Inhibition plus Sympathetic Denervation Is Superior to ACE Inhibitor Monotherapy in the Rat Renal Ablation Model (2007) (26)
Tamm Horsfall glycoprotein in diabetes mellitus: abnormal chemical composition and colloid stability (1988) (26)
Aldosterone and Parathyroid Hormone: A Complex and Clinically Relevant Relationship (2010) (25)
Renal reserve in the elderly. (1995) (25)
Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study. (2016) (25)
Evolution of IgA glomerulonephritis: relation to morphology, immunogenetics, and BP. (1987) (25)
Atherosclerosis in Dialyzed Patients (2004) (25)
Renin gene expression in human kidney biopsies from patients with glomerulonephritis or graft rejection. (1995) (25)
Effects of 1,25(OH)2D3 on compensatory renal growth in the growing rat. (1991) (25)
1,25(OH)2-vitamin D3 reduces spontaneous and hypocalcemia-stimulated pulsatile component of parathyroid hormone secretion. (1998) (25)
No aggravation of renal injury in apolipoprotein E knockout mice (ApoE(-/-)) after subtotal nephrectomy. (2004) (25)
Controversy on optimal blood pressure on haemodialysis: normotensive blood pressure values are essential for survival. (2001) (25)
Atherogenesis—Is It Accelerated in Uremia? (1989) (25)
Demonstration of the proliferation marker Ki-67 in renal biopsies: correlation to clinical findings. (1997) (25)
The effect of uninephrectomy on progression of renal failure in autosomal dominant polycystic kidney disease. (1992) (25)
Serum lipid changes on low salt diet. Effects of alpha 1-adrenergic blockade. (1993) (25)
Pathophysiology underlying accelerated atherogenesis in renal disease: closing in on the target. (2004) (25)
Vitamin D and Cancer Mortality: Systematic Review of Prospective Epidemiological Studies (2012) (25)
Nitrogen metabolism and growth in experimental uremia. (1980) (24)
Renal haemodynamics in the elderly. (1996) (24)
Glial cell line-derived neurotrophic factor (GDNF) is expressed in the human kidney and is a growth factor for human mesangial cells. (2000) (24)
Growth hormone induced rise in glomerular filtration rate is not obliterated by angiotensin-converting enzyme inhibitors. (1990) (24)
Adverse effect of smoking on renal function in the general population: are men at higher risk? (2002) (24)
Reducing lipids for CV protection in CKD patients-current evidence. (2008) (24)
Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial (2016) (24)
Parathyroid-independent change in renal handling of phosphate in hyperthyroid rats. (1979) (24)
The renal retinoid system: time-dependent activation in experimental glomerulonephritis. (2004) (24)
Cinacalcet hydrochloride for the treatment of hyperparathyroidism (2013) (24)
De novo glomerulonephritis in patients during remission from Wegener's granulomatosis. (1992) (24)
CONCOMITANT LYSOSOMAL STORAGE OF IRON AND ALUMINIUM IN DIALYSIS PATIENTS (1983) (24)
The epidemiology of end-stage renal disease in the Baltic countries: an evolving picture. (2001) (24)
Systemic hypertension versus intraglomerular hypertension in progression. (1994) (24)
Development of the circadian clockwork in the kidney. (2014) (24)
Bowel Perforation with Unused Tenckhoff Catheters (1989) (24)
Optimal haemoglobin during treatment with recombinant human erythropoietin. (1998) (24)
PTH pulsatility but not calcium sensitivity is restored after total parathyroidectomy with heterotopic autotransplantation. (2003) (23)
Diabetes – renal function – what are the special problems? (1998) (23)
Renal denervation: potential impact on hypertension in kidney disease? (2011) (23)
Renoprotective effects of renin-angiotensin-system inhibitors (2006) (23)
What is the appropriate dialysate calcium concentration for the dialysis patient? (1996) (23)
Erythropoietin Combined with ACE Inhibitor Prevents Heart Remodeling in 5/6 Nephrectomized Rats Independently of Blood Pressure and Kidney Function (2013) (23)
Effects of glucocorticoids on calcium and phosphate excretion. (1984) (23)
Chymase: a potential culprit in diabetic nephropathy? (2003) (23)
Non-occlusive mesenteric infarction in dialysis patients: the importance of prevention and early intervention. (1995) (23)
Interrelated aldosterone and parathyroid hormone mutually modify cardiovascular mortality risk. (2015) (23)
Bleeding in Uremic Patients after Carbenicillin (1976) (22)
Myocyte loss in early left ventricular hypertrophy of experimental renovascular hypertension (2003) (22)
Left Ventricular Hypertrophy in Renal Failure (1999) (22)
Reduced cardiac ischaemia tolerance in uraemia - what is the role of structural abnormalities of the heart? (1996) (22)
Kinetics of serum 1,84 iPTH after high dose of calcitriol in uremic patients. (1993) (22)
Dyslipidemia in chronic kidney disease: pathogenesis and intervention. (2009) (22)
Renal function and renal disease in males or females--vive la petite difference. (1998) (22)
Clostridium difficile diarrhoea in the immunosuppressed patient--update on prevention and management. (2004) (22)
Renal dysfunction as a cardiovascular risk factor (2002) (22)
Pathogenesis of renal osteodystrophy: roles of phosphate and skeletal resistance to PTH. (1978) (22)
Apolipoprotein A‐IV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus – a post hoc analysis of the 4D Study (2012) (22)
Edema and Congestive Heart Failure from Thiazolidone Insulin Sensitizers—Excess Sodium Reabsoption in the Collecting Duct Collecting Duct-Specific Deletion of Peroxisome Proliferator-Activated Receptor Blocks Thiazolidinedione-Induced Fluid Retention (2005) (22)
New insights into mechanisms of blood pressure regulation in patients with uraemia. (1996) (22)
Effect of PTH on osteocyte ultrastructure. (1978) (21)
Beta-2-microglobulin-derived amyloidosis: onset, distribution and clinical features in 13 hemodialysed patients. (1992) (21)
Chronic renal transplantation: a model for the hyperhomocysteinemia of renal insufficiency. (2001) (21)
Administration of Cyclosporine A in Pregnant Rats - the Effect on Blood Pressure and on the Glomerular Number in Their Offspring (2015) (21)
Attenuated rise of 1,25 (OH)2 vitamin D3 in response to parathyroid hormone in patients with incipient renal failure. (1991) (21)
Parathyroid hormone prevents 1,25 (OH)2D3 induced down-regulation of the vitamin D receptor in growth plate chondrocytes in vitro. (1997) (21)
Antibodies to neutrophil elastase: a study in patients with vasculitis. (1996) (21)
Autosomal dominant polycystic kidney disease--the patient on renal replacement therapy. (1996) (21)
Vocational Rehabilitation in Dialyzed Patients (1980) (21)
Osteodystrophy in the millennium. (1999) (21)
Growth hormone-induced glomerular hyperfiltration is dependent on vasodilating prostanoids. (1993) (21)
Aldosterone to Active Renin Ratio as Screening Test for Primary Aldosteronism: Reproducibility and Influence of Orthostasis and Salt Loading (2014) (21)
Pathophysiology of cardiovascular disease and renal failure. (2005) (21)
Clinical manifestations and natural history of diabetic kidney disease. (2013) (21)
An oral load of the early glycation compound lactuloselysine fails to accumulate in the serum of uraemic patients. (2006) (21)
Intermittent and continuous exposure to 1,25(OH)2D3 have different effects on growth plate chondrocytes in vitro. (1993) (21)
A polymorphism in the gene for the atrial natriuretic peptide and diabetic nephropathy. Diabetic Nephropathy Study Group. (1998) (20)
Role of Growth Hormone in Growth Failure of Uraemia ‐Perspectives for Application of Recombinant Growth Hormone (1988) (20)
Genetic determinants of diabetic renal disease and their impact on therapeutic interventions. (1997) (20)
Effect of parathyroid hormone, calcitonin and growth hormone on cAMP content of growth cartilage in experimental uraemia (1982) (20)
Progression of renal failure in the Han: SPRD polycystic kidney rat. (1994) (20)
Disorders of phosphate metabolism--pathomechanisms and management of hypophosphataemic disorders. (2003) (20)
Genesis and significance of hypertension in autosomal dominant polycystic kidney disease. (1994) (20)
125l-Angiotensin II Binding to Human Blood Cells (1985) (20)
Sodium chloride intake: is lower always better? (2012) (20)
47 Dietary Calcium Lowers Blood Pressure Without Accompanying Intravascular Volume Depletion (1984) (20)
Femoral head necrosis in uremic children without steroid treatment or transplantation. (1981) (20)
The clinical management of hyperphosphatemia. (2005) (20)
Calbindin-D28K and -D9K and 1,25(OH)2 vitamin D3 receptor immunolocalization and mineralization induction in long-term primary cultures of rat epiphyseal chondrocytes. (1995) (20)
Detrimental role of hyperuricemia on the cardio-reno-vascular system (2015) (20)
Effects of estrogens on cardiovascular structure in uninephrectomized SHRsp rats. (2005) (19)
Effect of vaccination schedule and dialysis on hepatitis B vaccination response in uraemic patients. (1983) (19)
Marinobufagenin in essential hypertension and primary aldosteronism: a cardiotonic steroid with clinical and diagnostic implications (2015) (19)
Demonstration and characterization of 1,25-dihydroxyvitamin D3 receptors in human mononuclear blood cells. (1984) (19)
Prenatal Causes of Kidney Disease (2009) (19)
Disturbed calcium metabolism in subjects with elevated diastolic blood pressure (1992) (19)
Structural causes of cardiac dysfunction in uremia. (1993) (19)
Association of methylenetetrahydrofolate reductase gene polymorphism and diabetic nephropathy in type 2 diabetes? (1999) (19)
Progression of renal disease--can we forget about inhibition of the renin-angiotensin system? (2006) (19)
Lead and the kidney. (1988) (19)
Hypertension, cardiovascular complications and survival in diabetic patients on maintenance haemodialysis. (1995) (19)
PRESERVATION OF KIDNEY FUNCTION BY USE OF CONVERTING-ENZYME INHIBITORS FOR CONTROL OF HYPERTENSION (1987) (19)
Effects of hemodialysis on platelets. (1987) (19)
Modulation of gene expression by moxonidine in rats with chronic renal failure. (2004) (19)
Ambulatory blood pressure monitoring: fancy gadgetry or clinically useful exercise? (2001) (19)
Secondary hyperparathyroidism and its therapy as a cardiovascular risk factor among end-stage renal disease patients. (2002) (19)
Functional, biochemical, and molecular investigations of renal kallikrein-kinin system in diabetic rats. (1999) (19)
Active Ca Transport of Sarcoplasmic Reticulum during Experimental Uremia (1976) (19)
Aldosterone, a vasculotoxic agent--novel functions for an old hormone. (2009) (18)
Early epoetin treatment in patients with renal insufficiency. (2000) (18)
Mobilizable lead in patients with chronic renal failure (1989) (18)
The message for World Kidney Day 2009: Hypertension and kidney disease: a marriage that should be prevented. (2008) (18)
Metabolic syndrome: an emerging threat to renal function. (2007) (18)
Preparation of the dialysis patient for transplantation. (2002) (18)
Hypertension in chronic idiopathic glomerulonephritis: analysis of 311 biopsied patients (1989) (18)
Renal failure: a state of nitric oxide deficiency? (2000) (18)
8 Renal osteodystrophy in uraemic children (1980) (18)
Acute cardiovascular effects of the calcimimetic R-568 and its enantiomer S-568 in rats (2009) (18)
Non-invasive circulating indicators of bone metabolism in uraemic patients: can they replace bone biopsy? (1996) (18)
Does the vitamin D receptor genotype predict bone mineral loss in haemodialysed patients? (1998) (18)
[The quality of the treatment of diabetics in kidney failure in Germany]. (2008) (18)
Hyperphosphatemia in Renal Failure (2004) (18)
Kidney and Hypertension—Causes (2003) (18)
Skeletal complications of renal insufficiency and maintenance haemodialysis. (1973) (17)
Altered action of angiotensin II in patients with type 2 diabetes mellitus of recent onset (1997) (17)
Corticosteroids and bone (1984) (17)
Adult Human Mesangial Cells (hmcs) Express Endothelin-b-receptors which Mediate Endothelin-1-induced Cell Growth (2000) (17)
The role of angiotensin I-converting enzyme gene polymorphism in renal disease. (1996) (17)
Genetic factors in IgA nephropathy. (1999) (17)
Low-salt diet downregulates plasma but not tissue kallikrein-kinin system. (1998) (17)
Inhibition of growth by calcitriol in a proximal tubular cell line (OK). (1994) (17)
Atherosclerotic complications after renal transplantation (2000) (17)
The history of urinary microscopy to the end of the 19th century. (1994) (17)
Role of infection in the genesis of acute renal failure. (1994) (17)
Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant vasculopathy in different aorta allotransplantation rat models. (2003) (17)
Acute hypophosphatemia. (1982) (17)
Severe hemorrhagic complications from infection with nephropathia epidemica strain of Hantavirus. (1992) (17)
Non-Occlusive Mesenteric Infarction (NOMI) in Dialysis Patients - Risk Factors, Diagnosis, Intervention and Outcome (1992) (17)
Abnormal expression and regulation of vitamin D receptor in experimental uremia. (1996) (17)
CHAPTER 29 – Pathogenesis, Clinical Manifestations, and Natural History of Diabetic Nephropathy (2010) (17)
Transmission of donor-derived small-cell carcinoma cells by a nontumor-bearing allograft. (2005) (17)
Vaccination against hepatitis B in patients with renal insufficiency. (1985) (17)
Dendritic cells in glomerulonephritis (1992) (16)
Phosphate, calcium and lipid metabolism. (1980) (16)
Bradykinin excretion is increased in severely hyperglycemic streptozotocin-diabetic rats. (1996) (16)
[Aim, design and methods of the "Hypertension and diabetes screening and awareness" -- (HYDRA) study]. (2003) (16)
N-acetylcysteine and contrast-induced nephropathy. (2006) (16)
Cardiovascular Structural Changes in Uremia: Implications for Cardiovascular Function (1999) (16)
Atherogenesis in experimental uremia. (1981) (16)
Effects of parathyroid hormone on osteocytes. Ultrastructural evidence for anisotropic osteolysis and involvement of the cytoskeleton (1978) (16)
Quantification of urinary insulin-like growth factors (IGFs) and IGF binding protein 3 in healthy volunteers before and after stimulation with recombinant human growth hormone. (1995) (16)
Chronic low-dose isotretinoin treatment limits renal damage in subtotally nephrectomized rats (2008) (16)
Beta-2-microglobulin-derived amyloid--problems and perspectives. (1988) (16)
Abnormal pulsatile secretion of growth hormone in non‐insulin‐dependent diabetes mellitus (1997) (16)
The Maillard reaction--from food chemistry to uraemia research. (1996) (16)
Human angiotensin II receptors are regulated by angiotensin II. (1988) (16)
Effect of angiotensin I converting enzyme inhibition on circulating atrial natriuretic peptide in humans. (1986) (15)
Serum lipids in renal insufficiency. (1978) (15)
[Acute granulomatous interstitial nephritis with iritis. Possible induction by non-steroidal antiphlogistics]. (2008) (15)
Anemia and diabetic nephropathy (2006) (15)
Acute effects of cigarette smoking on renal hemodynamics. (2000) (15)
Comprehensive immunohistological analysis of the endothelin system in human kidney grafts. (2006) (15)
Hypertension in diabetic nephropathy: prevention and treatment. (1993) (15)
Impact of hypertension on prognosis in IDDM. (1989) (15)
Acute phase reaction to gadolinium-DTPA in dialysis patients. (2008) (15)
Effect of 1,25-dihydroxycholecalciferol on sarcoplasmic reticulum calcium transport in strontium-fed chicks (2006) (15)
Biocompatibility of the polyamide membranes. (1992) (15)
Evaluation of clinical guidelines for the management of end-stage renal disease in europe: the EU BIOMED 1 study. (2000) (15)
Hypertension: the kidney is the culprit even in the absence of kidney disease. (2007) (15)
Renal, cardiovascular and metabolic effects of fetal programming. (2012) (15)
The BsmI vitamin D-receptor polymorphism and secondary hyperparathyroidism. (1997) (15)
Exposure of Pregnant Rats to Cigarette-Smoke Condensate Causes Glomerular Abnormalities in Offspring (2012) (15)
Nephropathy of type II diabetes mellitus. (1996) (15)
Mesangial IgA nephropathy and idiopathic nephrotic syndrome. (1987) (15)
1,25(OH)2D3 receptor regulation and 1,25(OH)2D3 effects in primary cultures of growth cartilage cells of the rat (1991) (15)
Reduction of silicone particle release during haemodialysis. (1985) (14)
Phosphate removal during dialysis--does the membrane matter? (1994) (14)
Calciuric response to 1,25-(OH)2D3 in early renal failure. (1985) (14)
Long-term therapy with cyclosporin A does not influence serum concentrations of vitamin D metabolites in patients with multiple sclerosis (1992) (14)
Particles from dialysis tubing stimulate interleukin-1 secretion by macrophages. (1990) (14)
Acute failure of the transplanted kidney--pathophysiology, diagnosis and prevention. (1996) (14)
Acrorenal syndrome in an adult--presentation with proteinuria, hypertension, and glomerular lesions. (1989) (14)
Synchronous fluctuations of blood insulin and lactate concentrations in humans. (1999) (14)
Edmund Randerath (1899-1961): experimental proof for the glomerular origin of proteinuria. (1999) (14)
[Endocrine regulation of calcium metabolism]. (1995) (14)
Influence of growth hormone and insulin-like growth factor-I on kidney function and kidney growth (1991) (14)
New insights into endocrine disturbances of chronic renal failure. (1992) (14)
Aldosterone and the kidney: a rapidly moving frontier (an update). (2014) (14)
Hypertension and kidney disease. (2011) (14)
Obesity and chronic kidney disease. (2009) (13)
Is atherogenesis accelerated in uremia (1986) (13)
Hypertension in diabetes mellitus. (1988) (13)
The reaction of different skeletal sites to metabolic bone disease — A micromorphometric study (1978) (13)
(CA)(n) dinucleotide repeat polymorphism at the 5'-end of the aldose reductase gene is not associated with microangiopathy in Caucasians with long-term diabetes mellitus 1. (2000) (13)
The message for World Kidney Day 2009: hypertension and kidney disease-a marriage that should be prevented. (2009) (13)
The optimal target hemoglobin. (2000) (13)
Preliminary studies on the renal handling of lactuloselysine from milk products. (2000) (13)
Albuminuria of hypertensive patients. (1992) (13)
Osteopathy in maintenance hemodialysis (2004) (13)
Remission of essential hypertension after renal transplantation. Commentaries (2000) (13)
[Indications for renal angiography and for percutaneous transluminal renal artery dilatation: interdisciplinary consensus statement regarding renal artery stenosis]. (2003) (13)
What is the evidence for activated coagulation in glomerulonephritis? (1982) (13)
Immunohistochemical features of mesangial IgA glomerulonephritis. (1984) (13)
The message for World Kidney Day 2009: hypertension and kidney disease--a marriage that should be prevented. (2009) (13)
New beta-lactam antibiotics and hemorrhagic diathesis: comparison of moxalactam and cefotaxime. (1983) (13)
Report from the Editorial Office (1996) (13)
Demonstration and characterization of 1,25-dihydroxyvitamin D3 receptors in basal cells of epidermis of neonatal and adult mice (1985) (13)
Regulation of Phosphate and Mineral Metabolism (1982) (13)
Hermann Senator and albuminuria--forgotten pioneering work in the 19th century. (2008) (13)
How Important Is Volume Excess in the Etiology of Hypertension in Dialysis Patients? (1999) (13)
Acquired cystic transformation of the kidneys of haemodialysed patients (2004) (13)
Night time blood pressure in diabetic patients--the submerged portion of the iceberg? (1999) (13)
Consequences of late referral in diabetic renal disease (2002) (13)
Morbidity, mortality and quality of life in the ageing haemodialysis population: results from the ELDERLY study (2016) (13)
[Diabetes, hypertension and microalbuminuria in primary care]. (2003) (13)
Progression of renal failure after subtotal nephrectomy in transgenic rats carrying an additional renin gene [TGR(mREN2)27] (1997) (12)
Nephrological complications of cancer therapy. (1982) (12)
Adverse effect of smoking on the renal outcome of patients with primary hypertension. (2000) (12)
Is there a renal phosphorus leak in recurrent renal stone formers with absorptive hypercalciuria? (1980) (12)
KIDNEY LESIONS IN URAEMIC PATIENTS AND β2-MICROGLOBULIN DERIVED AMYLOID (1985) (12)
Diabetes mellitus accounts for an ever-increasing proportion of the patients admitted for renal replacement therapy. (1989) (12)
Diabetic nephropathy--are there differences between type I and type II? (1990) (12)
Treatment of hypertension in dialysis patients. (1985) (12)
The Message for World Kidney Day 2009 (2009) (12)
Isotachophoresis for the determination of oxalate in unprocessed urine. (1981) (12)
Role of hormonal disturbances in uremic growth failure. (1986) (12)
Hemolytic uremic syndrome complicating postinfectious glomerulonephritis in the adult. (1995) (12)
[Acute kidney failure caused by Hantaan virus. Case report from the West Germany]. (2008) (12)
[Some topical problems of subtotal parathyroidectomy in patients on haemodialysis]. (1973) (12)
Hypertension and Cardiac Death in Dialysis Patients—Should Target Blood Pressure Be Lowered? (1993) (12)
[Does the care of diabetic patients with renal failure in the predialysis phase need improvement?]. (2008) (12)
Circadian rhythm of blood pressure in renal disease (2000) (12)
[Uremic patients--late referral, early death]. (2003) (12)
World Kidney Day 2009: hypertension and kidney disease is a marriage that should be prevented. (2009) (12)
Obesity and CKD: how to assess the risk? (2008) (12)
[Phosphate-depletion (author's transl)]. (1980) (12)
Nonhypotensive dose of β-adrenergic blocker ameliorates capillary deficits in the hearts of rats with moderate renal failure (2006) (12)
Bariatric surgery and the kidney—much benefit, but also potential harm (2012) (12)
Effect of control of diabetes mellitus on progression of renal failure. (1987) (12)
Febrile lady with acute renal failure and desquamating erythema. (1999) (12)
The charted and the uncharted waters of hyponatremia. (1987) (12)
Salt-sensitive blood pressure--an intermediate phenotype predisposing to diabetic nephropathy? (2005) (12)
The phosphate-depletion syndrome. (1978) (12)
Advances in nephrology: successes and lessons learnt from diabetes mellitus. (2001) (12)
Kidney damage in metabolic syndrome: nip it in the bud. (2009) (12)
Hypertension in the transplanted patient. (1998) (11)
Side effects due to materials used in hemodialysis equipment. (1985) (11)
Prevalence of dialysis-related amyloidosis in diabetic patients (1996) (11)
Control of sympathetic activity--new insights; new therapeutic targets? (2010) (11)
Spallation of dialysis materials--problems and perspectives. (1985) (11)
Endothelin antagonist as add-on treatment for proteinuria in diabetic nephropathy: is there light at the end of the tunnel? (2011) (11)
PREVENTION OF MICROALBUMINURIA IN TYPE 2 DIABETES (ROADMAP TRIAL): 6A.02 (2010) (11)
[Permissive effect of PTH on vascular wall hypertrophy of intramyocardial arteries in experimental renal failure]. (1996) (11)
The kidney in congestive heart failure. (1991) (11)
Lead and hypertension. (1992) (11)
Digitalis in chronic renal insufficiency. (1985) (11)
Optimizing antihypertensive therapy in patients with diabetic nephropathy. (1998) (11)
Treatment with high doses of loop diuretics in chronic renal failure. (1994) (11)
Effect of Endothelin Blockade on Early Cardiovascular Remodeling in the One-Clip-Two-Kidney Hypertension of the Rat (2003) (11)
Plasma parathyroid hormone, phosphatemia and vitamin D receptor genotype: are they interrelated? (2000) (11)
Diabetic nephropathy. (2006) (11)
Cardiac Findings in Experimental Uremia1 (1986) (11)
Cardiovascular problems in diabetic patients on renal replacement therapy. (2000) (11)
Detrimental and beneficial effects of converting enzyme inhibitors on the kidney. (1990) (11)
G(-699)/C polymorphism in the bradykinin-1 receptor gene in patients with renal failure. (2000) (11)
SH antigen in patients on long-term renal dialysis. (1970) (11)
Hypertension after renal transplantation. (2001) (11)
Kinetics of IS-5-MN and Its Glucuronide in Patients with Renal Failure (1985) (11)
Bone Mass In Maintenance Haemodialysis. Prospective Study with Sequential Biopsies (1976) (11)
Endothelin receptor antagonists in proteinuric renal disease: every rose has its thorn. (2010) (11)
PCR analysis of human renal biopsies--renin gene regulation in glomerulonephritis. (1994) (11)
Effect of vitamin D on growth cartilage cell proliferation in vitro (1991) (11)
Endothelin in renal diseases and cardiovascular remodeling in renal failure. (2001) (11)
Provocation of pulmonary haemorrhage in Goodpasture syndrome by chlorine gas. (1993) (11)
[New viewpoints on the role of vitamin D. Current knowledge and outlook]. (2008) (10)
Retinal vasculitis and uveitis--an adverse reaction to intravenous immunoglobulins? (1994) (10)
Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant nephropathy in a 'Fisher-to-Lewis' rat model. (2002) (10)
Skeletal lesions and calcium metabolism in early renal failure. (1975) (10)
chondrocytes in vitro (1997) (10)
Activation of human neutrophils after contact with cellulose-based haemodialysis membranes: intracellular calcium signalling in single cells. (1996) (10)
Effects of acute ACE inhibition on pulsatile renin and aldosterone secretion and their synchrony. (1998) (10)
The renal sinus cyst-the great imitator. (2000) (10)
Long-term administration of vitamin D steroles in incipient and advanced renal failure: effect on bone histology. (1978) (10)
Function of the sarcoplasmic reticulum (SR) in hypophosphatemic myopathy. (1980) (10)
How many patients with renal insufficiency survive until end-stage renal failure? (1991) (10)
Contrasting clinical course of Henoch-Schönlein purpura in younger and elderly patients. (1993) (10)
Drug holiday: a challenging child-adult interface in kidney transplantation. (2000) (10)
Antibody coating of bacteria in experimental infection of the urinary bladder. (1981) (10)
1,25(OH)2D3 receptors and endorgan response in experimental aluminium intoxication. (1987) (10)
Reversal of decreased phosphorylation of sarcoplasmic reticulum calcium transport ATPase by 1,25-dihydroxycholecalciferol in experimental uremia (2006) (10)
Bone cell kinetics and function during experimental uremia. (1981) (10)
Effect of converting enzyme inhibitors on cardiac changes in experimental uremia. (1988) (10)
Acid mucopolysaccharide metabolism in early atherosclerotic lesions. (1971) (10)
Phosphatemia is related to chromosomal aberrations of parathyroid glands in patients with hyperparathyroidism. (2007) (10)
Renal osteodystrophy studies with scanning and transmission electron microscopy. (1977) (9)
Renal dysfunction: a novel indicator and potential promoter of cardiovascular risk. (2003) (9)
Oxidative stress after uninephrectomy alters heart morphology in the apolipoprotein E −/− mouse (2008) (9)
Unchanged hormone sensitivity of rat fat cell adenylate cyclase in uremia. (1977) (9)
[Osteopathy in chronic dialysis]. (1972) (9)
Cardiovascular risk factors and urinary albumin: vive la petite difference. (2003) (9)
Does parathyroid hormone play a role in lipid metabolism? (1980) (9)
Clinical and serological features of mesangial IgA glomerulonephritis. (1983) (9)
Diabetic nephropathy--what have we learned in the last three decades? (1999) (9)
Mediators of inflammatory and ischemic renal damage: the role of neoangiogenesis. (2005) (9)
Simultaneous relapse of minimal-change glomerulonephritis and Graves' disease. (1997) (9)
Risk factors for development of diabetic nephropathy: a review. (1997) (9)
Clinical nephrology in 19th century Germany. (1994) (9)
Management of disturbed calcium metabolism in uraemic patients: 3. Potential perspectives--calcimimetics. (2000) (9)
Evidence for macrophage activation in dialysis patients exposed to silicone filing. (1985) (9)
Why are coronary plaques more malignant in the uraemic patient? (1999) (9)
Changes of bone histology during maintenance hemodialysis at various levels of dialyzate Ca concentration. (1976) (9)
Cardiac function in experimental uremia. (1983) (9)
Apolipoprotein AIV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus – a post hoc analysis of the 4 D Study (2012) (9)
The Message for World Kidney Day 2009: Hypertension and Kidney Disease: A Marriage That Should Be Prevented (2009) (9)
Experimental renal osteopathy. (1971) (9)
The living kidney donor: giving life, avoiding harm. (2003) (9)
Renal involvement in type II diabetes. (1994) (9)
Salt and the action of calcium antagonists. (1988) (9)
Proteinuria as a function of hypertension and age. (1993) (9)
Aldosterone in Uremia – Beyond Blood Pressure (2010) (9)
Physiological doses of calcium regulatory hormones do not normalize bone cells in uraemic rats (1999) (9)
French and German nephrologists in the mid-19th century. The impact of Richard Bright on the continent. (1989) (9)
Effect of ACE inhibitors, calcium channel blockers and their combination on renal and extrarenal structures in renal failure. (1995) (9)
Hypoprothrombinemia caused by cephalosporins. (1985) (9)
[Hypertension, diabetes mellitus and comorbidity in primary care]. (2003) (9)
The message for World Kidney Day 2009: hypertension and kidney disease—a marriage that should be prevented (2009) (9)
Dialysis bone disease. (1971) (9)
Single cell analysis of changes in cytosolic calcium induced by vitamin D3 metabolites in cultured rat mesangial cells. (1991) (9)
Glomerulonephritis and progression--Friedrich Theodor von Frerichs, a forgotten pioneer. (1997) (8)
Recurrent bloody dialysate during upper respiratory tract infection in mesangial IgA glomerulonephritis. (1987) (8)
SUBCUTANEOUS ERYTHROPOIETIN (1988) (8)
Endogenous calcitonin does not protect against hyperparathyroid bone disease in renal failure. (1986) (8)
Bone mineral content after renal transplantation (2005) (8)
Longitudinal Assessments of Erythropoietin-Stimulating Agent Responsiveness and the Association with Specific Clinical Outcomes in Dialysis Patients (2014) (8)
Incipient Pancreatitis Causing Cloudy Effluent in a Patient on CAPD (1986) (8)
Calcium and phosphorus metabolism in maintenance hemodialysis. (1980) (8)
Splenectomy in an uraemic patient with acquired factor X deficiency due to AL amyloidosis. (1998) (8)
Abdominal emergency in a dialysis patient: haemolysis from kinking of dialysis tubing. (1995) (8)
Does essential hypertension cause progressive renal disease? (1998) (8)
Pathogenesis of hypertension in glomerular disease. (1989) (8)
What is the Evidence for Accelerated Atherogenesis in Uremia? (1982) (8)
Acquired multicystic transformation of kidneys. (1985) (8)
Circulating Dopamine and C-Peptide Levels in Fasting Nondiabetic Hypertensive Patients (2012) (8)
Myopathy in experimental uremia (1975) (8)
The calcimimetic R-568 prevents podocyte loss in uninephrectomized ApoE-/- mice. (2013) (8)
Specific binding of angiotensin II and atrial natriuretic factor in non-nephropathic type I diabetes mellitus. (1989) (8)
[Guidelines for the treatment of arterial hypertension in diabetes mellitus. The consensus recommendations of the German League for the Fight against High Blood Pressure, Inc., the German Diabetes Society and the Society for Nephrology]. (1999) (8)
Allergic reactions to mesna (1991) (8)
Diminished response of ovarian cAMP to luteinizing hormone in experimental uremia. (1982) (8)
Is Control of Secondary Hyperparathyroidism Optimal with the Currently Used Calcium Concentration in the CAPD Fluid (1991) (8)
Hypertension and the kidney--an overview. (1993) (8)
[Vaccination of uremic patients against hepatitis B]. (2008) (8)
Pharmacokinetics of ramipril in hypertensive patients with renal insufficiency (2004) (8)
Influence of ACE inhibition on glucose tolerance in patients with stable chronic renal failure. (1995) (8)
Angiotensin receptor antagonists in patients with nephropathy due to type 2 diabetes (2002) (8)
Are recent findings on 1,25-dihydroxycholecalciferol metabolism relevant for the pathogenesis of uremia? (1986) (8)
The cultural history of smoking. (2000) (8)
[The clinical picture and therapy of Hantaan virus infection]. (1990) (8)
Is Beta-thromboglobulin a useful indicator of thrombosis in nephrotic syndrome? (1979) (8)
[Vena cava ultrasonography for the assessment of hydration status in kidney insufficiency]. (1993) (8)
PSEUDOPROTEINURIA IN PATIENTS TAKING PENICILLIN (1978) (8)
Scintigraphy in uremic bone disease. (1976) (8)
Calcimimetics—fooling the calcium receptor (2004) (8)
Cardiovascular risk factors and cardiovascular death in haemodialysed diabetic patients. (1985) (8)
SEQUENTIAL SCINTIGRAPHY IN RENAL TRANSPLANTATION. (1969) (8)
Homoarginine in Patients With Primary Hyperparathyroidism (2015) (8)
Circulating aldosterone and mortality in female nursing home residents (2013) (8)
Adult human mesangial cells (HMCs) express endothelin-B-receptors which mediate endothelin-1-induced cell growth. (2000) (8)
Osteocytes in chronic uremia (1973) (8)
Role of hypertension in diabetic nephropathy. (1989) (7)
[Vitamin D receptor gene polymorphism and the rate of bone loss of the femur neck and lumbar spine in hemodialized patients with chronic renal failure]. (1998) (7)
[Prevalence and pharmacotherapy of diabetes mellitus in primary care]. (2005) (7)
Blood pressure after renal transplantation. (2001) (7)
The dialysed lady with one swollen cheek. (1997) (7)
Nephrology in the Baltic countries. (1998) (7)
Losartan in Marfan Syndrome — Beyond Blood Pressure Lowering Losartan , an AT 1 Antagonist , Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome (2006) (7)
Clinical significance of the ANCA test for diagnosis of systemic necrotizing vasculitis. (1991) (7)
25-Hydroxyvitamin D3 metabolism in vitro by mononuclear cells from hemodialysis patients. (1992) (7)
Regulation of myocardial isomyosin V1 in uraemic rats (1991) (7)
Immunochemiluminometric assay with two monoclonal antibodies against the N-terminal sequence of human parathyroid hormone. (1996) (7)
The pathogenesis of hypertension in obese subjects. Discussion (1993) (7)
Antibody coating of urinary bacteria in transplanted patients. (1978) (7)
Hantavirus infection--new threats by an old virus. (1998) (7)
Urinary sIgA in Children With Urinary Tract infection (1987) (7)
Hemofiltration and Plasma Dopamine β-Hydroxylase Activity (1980) (7)
Antihypertensive Therapy in Renal Patients – Benefits and Difficulties (1999) (7)
Do β-blockers combined with RAS inhibitors make sense after all to protect against renal injury? (2007) (7)
Acquired renal cysts. (2001) (7)
Urinary slgA in children with urinary tract infection (1986) (7)
Pharmacokinetics and pharmacodynamics of lisinopril in advanced renal failure (1994) (7)
Effect of moxonidine on urinary electrolyte excretion and renal haemodynamics in man (2004) (7)
Does lead play a role in the development of renal insufficiency? (1988) (7)
[Health economic consequences of the use of irbesartan in patients in Germany with type 2 diabetes, nephropathy and hypertension]. (2004) (7)
Autosomal dominant polycystic kidney disease (ADPKD)--mechanisms of cyst formation and renal failure. (1993) (7)
RENAL TRANSPLANTATION IN INSULIN-DEPENDENT DIABETICS (1979) (7)
Zytomegalie-Virusinfektion bei hämodialysierten Patienten (1971) (7)
Calcium phosphate and magnesium balance in patients with acute illness (1998) (7)
Renal function and fluid-electrolyte homeostasis changes with age (1993) (7)
Statin use prolongs patient survival after renal transplantation. (2008) (7)
Letter: Methotrexate-citrovorum factor in treating osteogenic sarcoma. (1975) (7)
Explosion of renal replacement therapy after the implosion of the Soviet Empire. (2006) (7)
Cytomegalovirus infectian in hae-inodialysed patients. (1971) (7)
The nephrotic syndrome. (1998) (7)
Beta 2-microglobulin serum concentration and associated amyloidosis in dialysis patients. (1991) (7)
Adrenergic responsiveness in experimental uremia. (1984) (7)
Counteracting progression of renal disease: A look into the future. (2000) (7)
Blood pressure on dialysis: an ongoing controversy. (2002) (6)
[Diuretics in renal failure]. (1996) (6)
Georg Haas: A forgotten pioneer of haemodialysis (1998) (6)
Glycogen metabolism in phosphorus-depleted rats. (1983) (6)
The message for World Kidney Day 2009: hypertension and kidney disease— a marriage that should be prevented (2009) (6)
Prevalence and incidence of renal stone disease in a german population sample (1981) (6)
Treatment of cardiovascular changes in renal failure--ACE inhibition, endothelin receptor blockade or a combination of both strategies? (1999) (6)
Hypertension in mesangial IgA glomerulonephritis. (1985) (6)
Salt and hypertension (2010) (6)
Are antihypertensive drugs similar in protecting the kidney? (1995) (6)
Low-salt diet downregulates plasma but not tissue kallikrein-kinin system. (1998) (6)
[Diagnosis and differential diagnosis of hyponatremia]. (2008) (6)
Phosphate: are we squandering a scarce commodity? (2015) (6)
Blood pressure in diabetic nephropathy--current controversies. (2001) (6)
[Analgesics abuse--are phenacetin restrictions sufficient]. (2009) (6)
Renal research in 19th century Germany. (2010) (6)
Blood pressure in diabetic nephropathy – current controversies (2001) (6)
Parathyroidectomy in Secondary (Renal) Hyperparathyroidism - Whom, When, How? (1993) (6)
125I-Angiotensin II binding to human blood cells. (1985) (6)
Abnormal radiofurosemide binding by Tamm Horsfall glycoprotein of diabetic patients (1985) (6)
[Hypertension and diabetes mellitus]. (1990) (6)
The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented. (2009) (6)
Hypercalciuria and nephrolithiasis. (1985) (6)
[Australia antigen in fibrinogen concentrates and other coagulation active proteins]. (1970) (6)
The role of the kidney in cardiovascular medicine. (2005) (6)
Vasopressin in Hyponatremia: What Stimuli? (1986) (6)
Glycated hemoglobin predicts overall and cardiovascular mortality in non-diabetic hemodialysis patients. (2014) (6)
Abnormalities of glycogen metabolism in cardiomyopathy of phosphorous depletion. (1980) (6)
Topography of human urokinase activity in renal tissue. (1976) (6)
Regulation of intestinal vitamin D receptor expression in experimental uraemia: effects of parathyroidectomy and administration of PTH. (1998) (6)
Idiopathic interstitial nephritis complicating ulcerative colitis. (1990) (6)
[Radiological features of abnormal calcium metabolism in dialysis patients (author's transl)]. (1973) (6)
Factitious hypertensive crisis (Munchausen syndrome). (1996) (6)
Dialysis, cardiovascular disease, and the future (2007) (6)
Sympathetic Innervation of the Kidney in Health and Disease (2002) (6)
Renal involvement in type II diabetes. (1995) (6)
Prenatal causes of kidney diseases (2012) (6)
Hypertension in diabetes mellitus. (1988) (6)
Hemodialysis--from early days to tomorrow. (2005) (6)
Renal osteodystrophy in uraemic children. (1980) (6)
[Clinical and health economic implications of early treatment with irbesartan of patients with type 2 diabetes mellitus, hypertension and nephropathy]. (2006) (6)
Therapeutic Efficacy and Tolerance of Ramipril in Hypertensive Patients with Renal Failure (1989) (6)
Protein layer formation on artificial membranes. (1987) (6)
Activation of human neutrophils after contact with cellulose-based haemodialysis membranes: intracellular calcium signalling in single cells (1996) (6)
Nephropathy in type II diabetes. (2009) (6)
Smoking as a risk factor for end-stage renal failure in patients with primary renal disease. (2000) (6)
Treatment of polytransfused hemodialysis patients with recombinant human erythropoietin. (1988) (6)
DIABETIC NEPHROPATHY IN T2D PREVENTION AND PATIENT MANAGEMENT (2003) (5)
[Therapy of Wegener's granulomatosis and related vasculitides]. (2008) (5)
Wegener’s Granulomatosis, Microscopic Polyarteritis and Pauciimmune Crescentic Necrotizing Glomerulonephritis (1991) (5)
Endocrine disturbances of calcium metabolism in uremia: renal causes and systemic consequences. (1996) (5)
Australia Antigen in Various Plasma Fractions (1970) (5)
The 20210 G to A Prothrombin Polymorphism and Late Complications in Type 1 Diabetes Mellitus (1999) (5)
Gene Expression Profiling on Global cDNA Arrays Gives Hints Concerning Potential Signal Transduction Pathways Involved in Cardiac Fibrosis of Renal Failure (2003) (5)
Insect vectors in serum hepatitis. (1972) (5)
Pathophysiology and treatment of hypertension and oedema due to renal failure. (1994) (5)
Hantavirus infection presenting as acute renal failure (1990) (5)
Etiology of Left Ventricular Dysfunction in End-Stage Renal Failure (1992) (5)
Role of proteinase/antiproteinase inhibitor disequilibrium in the bioincompatibility induced by artificial surfaces. (1994) (5)
Survival and cardiovascular mortality in type I and type II diabetics with end stage renal disease (1994) (5)
The response of GFR to amino acids differs between autosomal dominant polycystic kidney disease (ADPKD) and glomerular disease. (1992) (5)
Phosphate and Mineral Homeostasis (1986) (5)
[Isolated systolic hypertension in old age]. (1993) (5)
Effects of angiotensin-converting enzyme inhibition on renal sodium handling after furosemide injection (1993) (5)
Parathormone and blood pressure in the spontaneously hypertensive rat. (1984) (5)
Uremic Cardiomyopathy — An Endogenous Digitalis Intoxication ? Central Role for the Cardiotonic Steroid Marinobufagenin in the Pathogenesis of Experimental Uremic Cardiomyopathy . Hypertension 47 : 488 – 495 (2006) (5)
Response of alkaline phosphatase to zinc repletion in hypozincemic hemodialysis patients. (1985) (5)
A One Day Cellulose Phosphate (CP) Test Discriminates Non-Absorptive from Absorptive Hypercalciuria (1985) (5)
Single-dose oral calcitriol and changes of plasma 1,84iPTH in uremic children. (1994) (5)
Effect of somatotropin(STH), parathyroid hormone (PTH) and calcitonin (CT) on cAMP-content of growth cartilage in uremia (1980) (5)
[Drug-induced haemorrhagic diathesis in uraemia (author's transl)]. (1973) (5)
Compounds in development to combat hyperphosphataemia (2001) (5)
Isotachophoretic Determination of Oxalate in Unprocessed Urine (1981) (5)
Excess cardiovascular mortality in the uremic patient--what does it teach for other risk factors in the non-renal patient? (1994) (5)
Pathophysiology and therapy of hypercalciuria in patients who form recurrent stones. (1975) (5)
[Nonocclusive intestinal ischemia as a complication of hemodialysis treatment]. (1993) (5)
The course of secondary hyperparathyroidism during chronic hemodialysis. (1968) (5)
How Can the Cardiac Death Rate be Reduced in Dialysis Patients? (2002) (5)
Preparation of sarcoplasmic reticulum with high calcium-sensitive ATPase and stable calcium transport function from rat skeletal muscle. (1981) (5)
Errors in ultrasonographic measurements of the kidney. (2000) (5)
[Systemic light-chain disease as a complication of plasmacytoma]. (2008) (5)
Horseshoe kidney. (1999) (5)
Decreased plasma phosphate under hormonal contraceptives. (1984) (5)
Iatrogenic multiorgan silicone inclusions in dialysis patients (1981) (5)
Does lead exposure contribute to deterioration of renal function in patients with renal disease? (1986) (5)
Different Relevance of Peripheral, Central or Nighttime Blood Pressure Measurements in the Prediction of Chronic Kidney Disease Progression in Patients with Mild or No-Proteinuria (2018) (5)
Intramural hematoma of the esophagus: a complication of carbon tetrachloride intoxication with acute renal failure. (1976) (5)
Bioincompatibility of dialysis membranes: factor H binding correlates inversely with complement activation indicating a local imbalance of involved proteases/anti-proteases. (1988) (5)
Kidney lesions in uraemic patients and beta 2-microglobulin derived amyloid. (1985) (5)
Antimicrobial therapy in dialysis patients. I. Penicillins and cephalosporins. (1985) (5)
Renal and cardiovascular events: do they deserve the same consideration in clinical trials? (2009) (5)
Influence of parathyroidectomy on blood pressure and vascular reactivity in spontaneously hypertensive rats. (1989) (5)
Structural changes of cortical bone in secondary hyperparathyroidism (1975) (5)
Reduced insulin-mediated glucose uptake by euglycemic clamp in offspring of patients with type 2 diabetes. (2009) (5)
[Diagnostic significance of antineutrophil cytoplasmic antibodies in Wegener's granulomatosis and related disease pictures]. (2008) (5)
[Hantavirus-induced acute renal failure]. (1996) (5)
Prescription of Calcium Concentration and Pth Control (1996) (5)
Metabolic control and blood pressure as risk factors for proliferative retinopathy in proteinuric type i diabetics (1986) (4)
Diabetic glomerulopathy: pathogenesis and management. (2000) (4)
Cardiac findings in experimental uremia. (1986) (4)
Ethylene oxide sterilization--a risk for hemodialysis patients. (1987) (4)
Is the renal risk of adults determined in utero? (2007) (4)
Fragmentocytes in the diagnosis of renal hematuria--observations in the 19th century. (1994) (4)
Isolation and renal localisation of urokinase. (1979) (4)
Effects of WY 47987 (atrial natriuretic factor 102-126) in patients with renal insufficiency: a placebo-controlled, randomised study. (1989) (4)
FETAL DEVELOPMENT IN EXPERIMENTAL UREMIA (1977) (4)
Specific angiotensin binding to human blood cells. (1983) (4)
[Vitamin D metabolism in kidney insufficiency: disorders of an endocrine regulatory zone]. (1979) (4)
Letter: Bleeding after carbenicillin administration. (1975) (4)
[Malignant hypertension. Significance of hypovolemia in pathogenesis and therapy of malignant hypertension]. (1976) (4)
Vasculotropic effects of calcimimetics (2010) (4)
Effect of uninephrectomy in ADPKD. (1995) (4)
Silicone filings in macrophages of viscera: an iatrogenic complication of haemodialysis. (1981) (4)
Differential effects of ACE inhibitors and vasodilators on renal function curve in patients with primary hypertension. (1993) (4)
[Bone changes in chronic renal insufficiency]. (1975) (4)
Prevalence of dialysis-related amyloidosis in diabetic patients. Diabetes Amyloid Study Group. (1996) (4)
New approaches to pathogenesis and management of hypertension. (2009) (4)
Haemodialysis-associated beta 2M amyloidosis: current controversies. (1994) (4)
Seminal contribution to dialysis. Comment (1998) (4)
Hyperparathyroidism and abnormal 1,25(OH)2vitamin D3 metabolism in experimental lead intoxication (1991) (4)
Nephroprotective Effect of ACE Inhibitors (2012) (4)
[Diagnostic significance of the lamina dura in secondary hyperparathyroidism (author's transl)]. (1978) (4)
[Kidney transplantation in the Federal Republic of Germany today]. (1976) (4)
Oral phosphate binders without aluminium and calcium - a pipe-dream? (1996) (4)
Hypertension in autosomal dominant polycystic kidney disease: is renin acquitted as a culprit? (2006) (4)
No 'Stinkefinger' and renal failure--do you see a link? Diagnosis: acrorenal syndrome. (1999) (4)
Evidence forin vivo upregulation of 1,25(OH)2 vitamin D3 receptor in human monocytes (1989) (4)
Pharmacological intervention in progressive renal diseases. (2001) (4)
Evidence for Dependance of Beta Thromboglobulin Levels on Renal Function (1979) (4)
Genesis of disturbed vitamin D metabolism in renal failure. (1995) (4)
Influence of dietary factors on the renal renin-angiotensin system. (1992) (4)
Hemofiltration and vascular stability. (1982) (4)
The kidney: both culprit and victim. (2009) (4)
Drug of Choice in the Management of Hypertension in Diabetes and Diabetic Nephropathy: Angiotensin‐Converting Enzyme Inhibitors (2011) (4)
Vitamin D Metabolism in Renal Disease (1992) (4)
Renin-dependent water intake in hypovolemia (1988) (4)
News from the editorial office (1995) (4)
Phosphate and Mineral Metabolism (1984) (4)
Acute flank pain in dialysed patients. Demonstration of hydronephrosis by computer tomography. (1980) (4)
Urinary sodium excretion in renal stone formers (1980) (4)
Optimal blood pressure control versus additional immunosuppressive therapy in idiopathic membranous nephropathy - a retrospective analysis. (2009) (4)
Secondary (renal) hyperparathyroidism ― Diagnosis and medical management (1986) (4)
[Disorders of Ca metabolism in chronic renal insufficiency]. (1971) (4)
Papillary necrosis in a ballet dancer with no history of analgesic abuse. (1996) (4)
Digitalis Intoxication and Hyperkalemia in Hemodialysed Patients (1981) (4)
Vitamin D therapy in patients receiving dialysis. (1995) (4)
Patterns of lead excretion in patients with gout and chronic renal failure--a comparative German and Australian study. (1987) (4)
Epidemiology of Urolithiasis and Calcium Metabolism in Human Diabetes Mellitus (1985) (4)
Subacute effects of thiazide administration on renal hemodynamics and calcium metabolism (1992) (4)
Endothelin Receptor Antagonists in Diabetic Nephropathy (2010) (3)
[Hemodialysis and transplantation in uremic diabetic patients?]. (1979) (3)
Analysis of clinical laboratory data by biplot methods using a three-dimensional display: discrimination of renal stone-patients with idiopathic hypercalciuria and primary hyperparathyroidism. (1979) (3)
Different effects of oral glycine and methionine on urinary lithogenic substances. (1983) (3)
Pathophysiology of renal disease. Heidelberg Seminars in Nephrology 1980. (1980) (3)
Parathyroid activity in hyperthyroidism (1975) (3)
[Beta 2-microglobulin-induced amyloidosis. A new complication of long-term hemodialysis]. (2008) (3)
Digitalis treatment in uremic patients. (1984) (3)
Different in vitro generation of C3d by cuprammonium and polycarbonate capillary hemodialyzers. (1986) (3)
Osteodystrophy in experimental uremia. (1988) (3)
Atherogenesis in uremia. (1984) (3)
OR-49: Treatment based on a low dose combination of perindopril and indapamide reduces albuminuria more effectively than enalapril in hypertensive type 2 diabetic patients (2002) (3)
Angiotensin Dependent Thirst Following Polyethyleneglycol Treatment in the Rat (1986) (3)
[Interstitial myocardial fibrosis in chronic uremia--the cause of chronic diastolic malfunction in dialysis patients?]. (1989) (3)
Sympathetic activity (plasma-dopamine-beta-hydroxylase) in haemofiltration and haemodialysis. (1978) (3)
Not all phosphate is created equal. (2012) (3)
Plasma Dopamin-β-hydroxylase-activity in dialysed patients (1977) (3)
Effects of acute and chronic PTH stimulation on osteoblasts and the under-lying bone matrix (1975) (3)
The effect of 1,25 (OH)2D3 on bone mineralization: ultrastructural studies in patients with renal osteodystrophy. (1980) (3)
Myopathy of uremia. (1984) (3)
Vascular calcifications under maintenance hemodialysis (1977) (3)
[Clinical signs and diagnosis of hyperkalemia]. (2008) (3)
Impact of oral calcium on mortality of dialysis patients--an underestimated risk? (2012) (3)
The kidney in disorders of calcium metabolism. (1977) (3)
Nephrology beyond JASN (2006) (3)
AIPRI : Angiotensin-converting-enzyme inhibition in progressive renal insufficiency (1996) (3)
Non-A, non-B hepatitis in hemodialysis. (1983) (3)
Diabetic kidney disesase. (2014) (3)
[Calcium antagonists in chronic renal failure. Undesirable effects on glomerular hemodynamics?]. (1988) (3)
SKELETAL GROWTH IN UREMIA (1974) (3)
Osteopathy in experimental uremia (1971) (3)
Accessory Renal Arteries — Mostly , But Not Always , Innocuous Renin-Dependent Hypertension Caused by Nonfocal Stenotic Aberrant Renal Arteries — Proof of a New Syndrome . Hypertension (2005) (3)
Office and ambulatory pulse pressure—association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study) (2011) (3)
Rapidly progressive glomerulonephritis in a patient with Henoch-Schoenlein purpura. Spontaneous recovery of renal function after six months of maintenance hemodialysis. (1995) (3)
Bicarbonate dialysis--so what? (1985) (3)
[Diuretics and kidney diseases]. (2000) (3)
Haemodynamics and myocardial metabolism of phosphorus depleted dogs: effects of catecholamines and angiotensin II (1982) (3)
Is More Heparin Necessary for Low-Dose Heparin Prophylaxis in Uremic Patients? (1981) (3)
Gdansk bio-statistic and epidemiology course. (2001) (3)
Circulatory response to pressor agents in phosphorous depletion. (1982) (3)
The involvement of plasmatic and fibrinolytic systems in idiopathic glomerulonephritis (GN). (1984) (3)
[Postpartum aortic rupture in coarctatio aortae]. (1966) (3)
Vocational rehabilitation in dialyzed patients. A cross-sectional study. (1980) (3)
Lead intoxication — new insights into an old problem (1992) (3)
The EDTA Registry—dilemma and hope (1995) (3)
Rational drug treatment of the hypertensive diabetic with nephropathy. (1988) (3)
Antibody-coated bacteria in ejaculate in bacterial prostatitis. (1984) (3)
The role of hypertension in diabetic nephropathy. (1990) (3)
Prevalence of microalbuminuria in type 2 diabetes: lessons learned from the ROADMAP study. (2012) (3)
Can we ameliorate quality of life in chronic kidney disease? The nephrologist's point of view. (2008) (3)
END-STAGE RENAL FAILURE DUE TO DIABETIC NEPHROPATHY IN SPAIN. AUTHORS' REPLY (1996) (3)
Carbohydrate Metabolism in Kidney Disease and Kidney Failure (2013) (3)
Role of intracellular calcium and calmodulin in cellular metabolism: possible implications for renal failure. (1983) (3)
The role of testicular adenylate cyclase in the hypogonadism of renal insufficiency. (1978) (3)
Kidney and hypertension-causes. Update 2003. (2003) (3)
Organ and Metabolic Complications: Lipids/Atherosclerosis (1996) (3)
Clinical relevance of albuminuria in hypertensive patients (2004) (3)
The influence of acetylsalicylic acid on platelet adhesiveness and thrombotic fistula complications in hemodialysed patients (1971) (3)
Cardiovascular disease in patients with chronic kidney disease-An update (2010) (3)
Thromboembolic complications and haemostasis in the nephrotic syndrome--is there a difference between children and adults? (1983) (3)
Reduction of microalbuminuria by beta blockers: beyond renin-angiotensin system blockade. (2005) (3)
How Little Aldosterone is Able to Raise Blood Pressure (2009) (3)
[Therapy of hyponatremia]. (2008) (2)
Disturbed growth in uremia: are hormonal factors responsible? (1988) (2)
Carriage of Australia antigen by cockroaches. (1972) (2)
[Intervention in renal artery stenosis: quite appropriate in selected cases]. (2001) (2)
Active Ca transport of sacroplasmic reticulum during experimental uremia. Changes in kinetics and lipid composition. (1976) (2)
Renal bone disease (1999) (2)
[Is asymptomatic hyperuricemia in kidney-failure patients in need of therapy?]. (2009) (2)
Hemodynamics and cardiac metabolism in experimental uremia. (1984) (2)
[Occupational rehabilitation and evaluation of patients with renal failure]. (1981) (2)
Kidney and Blood Pressure — The Story Unfolds Renalase Is a Novel , Soluble Monoamine Oxidase That Regulates Cardiac Function and Blood Pressure (2005) (2)
Do antibody-coated bacteria prove bacterial prostatitis? (2005) (2)
Pathophysiology and treatment of uremic bone disease (1983) (2)
[Serum level and organ deposits of beta 2-microglobulin in dialysis patients]. (1990) (2)
[Disorders of calcium and phosphate homeostasis]. (1999) (2)
Cardiovascular complications after renal transplantation (1999) (2)
Intestinal transport of calcium in experimental uremia. (1971) (2)
[Vitamin D activity in the serum of uremic patients]. (1969) (2)
Hyperparathyroidism: Influence of glomerular filtration rate on urinary excretion of cyclic AMP (1977) (2)
[Retro-orbital fibrosis in Ormond's disease (author's transl)]. (1974) (2)
[Prophylactic treatment of epileptic patients with vitamin D2 and D3. Results of a comparative study of 86 patients (author's transl)]. (1978) (2)
[Thrombotic occlusion of an arteriovenous Cimino shunt in acute pancreatitis (author's transl)]. (1975) (2)
PPARgamma agonists: killing two birds with one stone? (2004) (2)
Suicide by eating bananas. (1969) (2)
Rapid Publication No 1 , 25-Dihydroxyvitamin D 3 Receptors on Osteoclasts of Calcium-deficient Chicken Despite Demonstrable Receptors on Circulating Monocytes (2)
Compelling drug indications in diabetic and nondiabetic nephropathy (2004) (2)
Ultrastructure of the Rat Testis in Experimental Uremia (2009) (2)
DILATATION TO AVOID DIALYSIS: ANGIOPLASTY OF AN OCCLUDED RENAL ARTERY WITH A CORONARY GUIDING CATHETER (1985) (2)
Does Arachidonic Acid Interfere with Measurements of Thromboxane (TXB2)? (1982) (2)
Serum Phosphate : A Novel Cardiovascular Risk Factor Even in Nonrenal Patients Relation between Serum Phosphate Level and Cardiovascular Event Rate in People with Coronary Disease (2006) (2)
[Is their an idiopathic pericarditis in hemodialysis patients?]. (1974) (2)
Effect of vitamin D3 and 1.25 (OH)2 D3 on growth in experimental uremia(EU) (1980) (2)
1,25-Dihydroxyvitamin D3 action and receptors in endothelial and smooth muscle cells of arterial vessels (1987) (2)
Bone volume and mineral density of iliac crest spongiosa in uremia. (1975) (2)
l-Fucose residues on cellulose-based dialysis membranes: Quantification of membrane-associatedl-fucose and analysis of specific lectin binding (1995) (2)
[A rapid rise in the number of type-2 diabetics in kidney failure. Not just a problem of nephrologists]. (1996) (2)
Current and future challenges in anaemia management. (2005) (2)
Diabetic Nephropathy—the Size of the Problem (2001) (2)
[Diagnosis of nephrolithiasis]. (2008) (2)
Risk Factors for Progression of Chronic Kidney Disease (2009) (2)
Pseudoporphyria Cutanea Tarda and Non-A Non-S Hepatitis in a CAPD Patient (1987) (2)
Azotemic osteodystrophy - indications for intervention. (1980) (2)
β2 Microglobulin-Derived Amyloid in Dialysis Patients (1989) (2)
Bacterial infections in diabetes mellitus: are calcium channel blockers beneficial? (1997) (2)
What have nephrologists and cardiologists learnt from each other? (2009) (2)
Hypertension in Diabetics with Renal Disease (1988) (2)
[Lupus nephritis. When, how and with what should it be treated?]. (2008) (2)
Nephrolithiasis in Dialysed Patients — Evidence for a Peculiar Type of Matrix Stones with Ca-Oxalate Inclusions (1981) (2)
[Experience with ion exhcange resins in the calcium phase during the management of hyperkalemia]. (1969) (2)
Statement Nephrology Dialysis Transplantation Analgesic nephropathy (2005) (2)
The Spectrum of Skeletal Manifestations in Renal Osteodystrophy (1981) (2)
Hypertension: The message of World Kidney Day 2009 (2009) (2)
H2 - Differential effects of antihypertensive treatment on the development of glomerulosclerosis in subtotally nephrectomized rats (1995) (2)
[Antihypertensive therapy and progression of renal failure]. (1987) (2)
Isotachophoretic determination of urinary citrate in native urine. (1980) (2)
Preparation (Agar Zone Electrophoresis) and Immunological Characterisation of Urokinase (1977) (2)
[From Digitalis purpurea to toad skin. An historical view of digitalis-like mammalian hormones ]. (2008) (2)
Perirenal capsula adiposa--is it a sign indicating diabetes mellitus? (1996) (2)
Phosphate Depletion Syndrome (1984) (2)
Storage of silicone particles in macrophages: an iatrogenic complication in dialysis patients. (2008) (2)
Recent findings on 1,25(OH)2 vitamin D3 may provide new concepts for understanding the pathogenesis of uremia. (1986) (2)
25-OH-vitamin D in experimental and clinical uremia (1976) (2)
[Acquired cystic kidney disease and autosomal dominant polycystic kidney disease--precancerous condition?]. (1989) (2)
Immunoglobulin constant heavy chain gene polymorphisms of Caucasoids of west European origin. (1991) (2)
[Management of diabetes and hypertension: how do primary care physicians judge their performance?]. (2003) (2)
Cardiac function and metabolism in phosphorous depleted dogs--effects of hormonal stimulation. (1982) (2)
The Message for World Kidney Day 2009 (2009) (2)
Immunologic abnormalities in Wegener's granulomatosis. (1983) (2)
Preservation of Renal Function in Diabetic Patients (1991) (2)
[What has been achieved in the therapy of calcium nephrolithiasis?]. (1979) (2)
PRIMARY HYPERPARATHYROIDISM: INFLUENCE OF RENAL FUNCTION ON URINARY CYCLIC AMP (1974) (2)
HLA-DP region gene polymorphism in primary IgA nephropathy: no association. (1992) (2)
SYNTHESIS OF CHONDROITIN SULFATE IN EXPERIMENTAL HYPOTHYROIDISM (1974) (2)
Foetal development in experimental uraemia. (1973) (2)
Novel classification of glomerulonephritis in the monograph of Franz Volhard and Theodor Fahr. (1998) (2)
Deposition of polymeric IgA1 in idiopathic mesangial IgA-glomerulonephritis (1983) (2)
The kidney in Type 2 (non-insulin-dependent) diabetes mellitus (1993) (2)
Foreign body giant cell reaction in lungs, liver and spleen (1981) (2)
The apparent "epidemic" increase in the incidence of renal failure from diabetic nephropathy. (1993) (2)
Hyperlipoproteinemia in phosphate depletion. (1984) (2)
Effect of phosphate depletion on gluconeogenesis in isolated rat hepatocytes. (1984) (2)
Opinion: How Can the Poor Outcomes for Diabetic Dialysis Patients be Improved? (2004) (2)
DIALYZING THE ELDERLY: ISSUES AND CONCERNS: Cardiovascular Abnormalities and Hypertension in the Elderly Dialysis Patient (2002) (2)
Lowering salt intake—an important strategy in the management of renal disease (2007) (2)
OACE inhibition does not interfere with acute extrarenal or renal potassium disposal in chronic renal failure (2004) (2)
Early treatment of renal osteodystrophy. (1984) (2)
Defective hormonal stimulation of isolated hepatocytes in phosphorous depleted rats. (1982) (2)
[Clinical experiences in antihypertensive treatment with guanabenz or clonidine in combination with thiazide]. (1978) (2)
Heinrich Necheles: Pioneer of Hemodialysis in the Treatment of Experimental Uremia (2012) (2)
Effects of parathyroidectomy on blood pressure development in eucalcaemic, spontaneously hypertensive rats. (1983) (2)
Do limited changes in phosphate intake modulate 1,25(OH)2D3 levels in early renal failure? (1992) (2)
The diabetic patient with renal failure. (2000) (2)
Pathophysiological problems in clinical nephrology (1978) (2)
[Letter: Retro-orbital fibrosis in Ormond'sdisease]. (1975) (2)
1,25-dihydroxyvitamin D3 inhibits parathyroid cell proliferation in experimental uremia (1989) (2)
Hypothesis: calcium carbonate as phosphate binder--the fallacy of relying on serum phosphorus. (2010) (2)
High-density lipoprotein composition in chronic hemodialysis. (1979) (2)
[The renin-angiotensin system in diabetic patients]. (1988) (2)
[Hemodialysis using the upper-arm fistula. Hemodynamic examinations and clinical experiences]. (1973) (2)
Chapter 70 – Cardiovascular Complications of End-Stage Renal Disease (2008) (2)
Impact of renal dysfunction as a cardiovascular risk factor. (2005) (1)
Non-diabetic nodular glomerulosclerosis recurring in a renal graft. (2000) (1)
A1Pressure independent changes of elastic and peripheral arteries and veins in uremia. (1995) (1)
[Current problems of kidney transplantation in the Federal Republic of Germany and West Berlin]. (1972) (1)
[The therapy of vasculitis]. (1996) (1)
[The pentose cycle in arterial tissue]. (1968) (1)
Reaction patterns of the myocardial interstitium in different models of cardiac hypertrophy--stereological investigations. (1989) (1)
LIFE ON HÆMODIALYSIS (1975) (1)
Disturbed Terminal Mineralization of Bone in Idiopathic Hypercalciuria (1981) (1)
1P-0289 Atorvastatin in patients with type 2 diabetes on hemodialysis: Design and baseline characteristics of a double-blind clinical trial (Die Deutsche Diabetes Dialyse Study) (2003) (1)
[Experimental studies on the pathogenesis of osteopathy in uremia]. (1971) (1)
Cinacalcet (Mimpara (R)/Sensipar (R)) effectively reduces intact parathyroid hormone (iPTH) and serum calcium (Ca) regardless of serum calcium level in patients with secondary hyperparathyroidism (HPT) (2005) (1)
Nutrition in Paediatric Renal Disease (1984) (1)
International Nephrological Symposium, 'Modern aspects of renal replacement therapy'. Moscow, Russia, 8-9 September 1998 (1999) (1)
[Antihypertensive treatment in kidney diseases: whom, with what, how intensively?]. (2009) (1)
Purification of Human Urokinase and its Topographical Localisation in Renal Parenchyma (1975) (1)
[Smoking -- the futile fight against the vice. A historical perspective]. (2005) (1)
[Rational diagnosis of hematuria]. (2008) (1)
[Disorders of calcium metabolism in kidney failure]. (1972) (1)
The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented. (2009) (1)
Effects of l α,25-Dihydroxyvitamin D3 on Compensatory Renal Growth in the Growing Rat (1993) (1)
Joint action nephrology in Eastern Europe (1996) (1)
ACE inhibition and renal protection. (1992) (1)
Altered beta-receptor responsiveness in uraemic rats. (1983) (1)
INCREASED l,25(OH)2D3 RECEPTOR LEVEL IN THE INTESTINE AND PARATHYROID OF THE SUBTOTALLY NEPHRECTOMIZED RAT (1991) (1)
CHAPTER 88 – Role of Glomerular Pressure in Progression (2008) (1)
Natriuretic factors and lithium clearance in patients with the syndrome of inappropriate antidiuretic hormone (SIADH) (1989) (1)
[ACE inhibitors and kidney]. (1990) (1)
Prevalence of immunecomplex-associated glomerulonephritis in hypertensive subjects. (1994) (1)
Beta 2 microglobulin-derived amyloid in dialysis patients. (1989) (1)
[Aluminum accumulation and deferoxamine]. (1993) (1)
Presumable non-A, non-B hepatitis in hemodialysis. (1982) (1)
Lack of involvement of sarcoplasmic reticulum in myopathy of acute phosphorous depletion (1980) (1)
[Converting enzyme inhibitors in preterminal renal failure]. (1992) (1)
[Nephropathy and hypertension in type II diabetes]. (1997) (1)
Secondary hyperparathyroidism resistant to active vitamin D is not unique to renal failure--observation in a patient with distal tubular acidosis and pancreatogenic malabsorption. (1998) (1)
[Physiopathological problems of osteopathy in long term hemodialysis]. (1973) (1)
[Osteopathy and growth retardation of the child's skeleton in uremia]. (1975) (1)
Renal 31-phosphorus-magnetic resonance spectral changes in experimental uremia. (1996) (1)
Bone surface in secondary hyperparathyroidism. An SEM study (1976) (1)
[The devil takes the hindmost]. (2006) (1)
[High blood pressure and kidneys--the contribution of Franz Volhard]. (2000) (1)
Do antibody-coated bacteria reflect local immune response in the urinary tract? (1984) (1)
Intestinaler Calciumtransport bei Urämie (1969) (1)
Long-term therapy with cyclosporin a does not influence serum concentrations of vitamin D metabolites in humans (1992) (1)
Endstage renal failure in diabetes type II ‐ a silent epidemic (1998) (1)
Clinical problems of diuretic treatment (1994) (1)
Angiotensin Receptor Blocker to Prevent Microalbuminuria (2012) (1)
[The kidney in the Bible]. (2006) (1)
Factors influencing the effect of parathyroid hormone on endosteal cell morphology. A scanning electron microscope study (1976) (1)
Protein-energy wasting (2013) (1)
Osteocalcin in adolescents with chronic renal failure (1988) (1)
Contrasting renal haemodynamic effects of protein in normal subjects and glomerulonephritic patients with impaired renal function. (1993) (1)
SERUM 25-OH-VITAMIN D IN PRIMARY HYPERPARATHYROIDISM (1975) (1)
[A critical analysis of micromorphometry in metabolic osteopathy (author's transl)]. (1974) (1)
Letter: Sodium depletion in accelerated hypertension. (1975) (1)
Desk Top Calculator Program for Evaluation of Clinical Chemistry Results in Recurrent Stone-Formers (1976) (1)
Influence of vitamin D treatment on serum levels of parathyroid hormone fragments in patients with chronic renal failure (1975) (1)
Does occupational exposure to toxins increase albumin excretion rate? (1998) (1)
[Therapy of glomerulonephritis]. (1995) (1)
[Recurring urinary tract infection in the female. Recent viewpoints on pathogenesis and therapy]. (1979) (1)
THE MANAGEMENT OF RENAL INSUFFICIENCY (1984) (1)
[Experimental autoradiographic investigations of the collagen metabolism of bone in uremia]. (1972) (1)
The bedridden osteomalacic patient with Fanconi syndrome in pre-terminal renal failure. (2000) (1)
[Epidemiological studies of the frequency of the abuse of analgesics]. (1990) (1)
Angiotensin converting enzyme inhibitors and nephroprotection (1995) (1)
Cardiovascular disease in chronic renal failure. Risk factors and prevention. (2004) (1)
[Acid mucopolysaccharide metabolism in normal and arteriosclerotic human arteries]. (1969) (1)
[Kidney involvement in scleroderma]. (2008) (1)
Application of an improved methodology to demonstrate bacterial adherence during the menstrual cycle (1981) (1)
Different antagonist potency of saralasin in acute and chronic angiotensin-dependent hypertension. (1983) (1)
Wegener's granulomatosis, microscopic polyarteritis and pauciimmune crescentic necrotizing glomerulonephritis, an overview. (1992) (1)
Cadmium-induced renal damage: fact and fiction (1986) (1)
GENETICS OF THE RENIN - ANGIOTENSIN CONVERTING ENZYME AND RENAL DISEASE (1997) (1)
EFFECT OF CYCLOSPORINE A ADMINISTRATION IN PREGNANT RATS ON BLOOD PRESSURE IN THEIR OFFSPRING: PP.33.111 (2011) (1)
[Therapy of hyperkalemia]. (2008) (1)
Should all patients with chronic kidney disease take a statin? A commentary to a meta-analysis of randomized control trials. (2008) (1)
[Rejection of the transplanted kidney]. (1972) (1)
Australia Antigen in Chronic Hemodialysis (1970) (1)
[Nephroprotection with ACE inhibitors]. (1991) (1)
[Roentgenologic signs of disturbed calcium metabolism in dialysis patients. I. Frequency of roentgenologic skeletal changes]. (1973) (1)
CKD LAB METHODS, PROGRESSION & RISK FACTORS 1 (2014) (1)
Are newer antihypertensive agents really more effective than traditional drugs in progressive renal disease? (1991) (1)
Specific organ protection by blocking the renin-angiotensin system. (2001) (1)
Interstitial nephritis in a patient with atypical Sjörgen's syndrome (1980) (1)
[Incidence of bacteriuria in hormonal contraception]. (1976) (1)
331. Gonadal 1,25 (OH)2D3 receptor and action of 1, 25(OH)2D3 on LH stimulated testicular and ovarian camp response (1982) (1)
Unmet clinical needs in dialysis: what can we do? (2001) (1)
The effect of thyroxine on renal phosphorus handling (1974) (1)
Vitamin D 3 -Triggered Antimicrobial Response—Another Pleiotropic Effect beyond Mineral and Bone Metabolism (2006) (1)
[The significance of 24-hour blood pressure monitoring in patients with diabetes mellitus]. (1999) (1)
[Does an association between angiotensin I converting enzyme gene polymorphism and the prevalence of diabetic nephropathy in patients with diabetes type II exist?]. (1995) (1)
H1DIFFERENTIAL EFFECTS OF ANTIHYPERTENSIVE TREATMENT ON ABNORMAL CARDIAC STRUCTURE IN EXPERIMENTAL UREMIA (1995) (1)
Hypercalcaemic acute renal failure--a complication of granuloma annulare elastolyticum. (1998) (1)
Reversible Thrombopenie bei klinischer Anwendung von Anti-lymphocytenserum (2005) (1)
[Sodium at the crossroads of history and culture]. (2007) (1)
The patient with ADPKD on maintenance hemodialysis. (1995) (1)
Rickets due to calcium deficiency. (1978) (1)
[Combination therapy with angiotensin receptor blockers and ACE inhibitors - contra]. (2009) (1)
Comment on "Baroreceptor, not Left Ventricular, Dysfunction is the Cause of Hemodialysis Hypotension" by Heber et al. (1989) (1)
[Current status (15.11.1970) of kidney transplantation in the Federal Republic and West Berlin]. (1971) (1)
[Lactic acidosis--a possible complication in buformin-treated diabetics (author's transl)]. (1978) (1)
[Changes in the gastric mucosa in experimental uremia. Behavior of the parietal cells in the gastric mucosa of uremic mice. An autoradiographic study]. (1971) (1)
Hemofiltration and plasma dopamine beta-hydroxylase activity. (1980) (1)
Drunken driving and renal failure--do you see a link? (1999) (1)
ROADMAP OBSERVATIONAL FOLLOW-UP STUDY: BENEFITS OF RAAS BLOCKADE WITH OLMESARTAN TREATMENT ARE SUSTAINED AFTER STUDY DISCONTINUATION (2014) (1)
Effect of cyclosporine A administration in pregnant rats on blood pressure in their offspring (2011) (1)
Glucuronic acid cycle in arterial tissue (1970) (1)
Conjectures and Refutations Phosphate : are we squandering a scarce commodity ? (2015) (1)
The five most cited NDT articles from 1993 to 1999. (2010) (1)
Letter: Specific uremic cardiomyopathy. (1976) (1)
Mineralocorticoid receptor blockade—a novel approach to fight hyperkalaemia in chronic kidney disease (2013) (1)
[Microalbuminuria is an early marker for increased morbidity and mortality]. (2003) (1)
[Clinical and experimental studies on uremic gastritis]. (1971) (1)
The alcoholic patient with an acute nephrotic syndrome and resistance to diuretics. (1997) (1)
Salt- and Volume-Regulating Systems (1989) (1)
[Acute interstitial pulmonary fibrosis in Paraquat poisoning. Clinico-anatomical observation of a case with fatal outcome]. (1969) (1)
Nephropathy in Type II diabetes (1996) (1)
Hypophosphatemia in Recurrent Renal Stone Formers — Consequence of Arterial Hypertension? (1981) (1)
[Reflections on the World Congress for Nephrology]. (2003) (0)
[Acute myoglobinuric kidney failure in McArdle's syndrome. The diagnostic significance of 31P nuclear magnetic resonance spectroscopy]. (1993) (0)
[The progression of kidney failure]. (1993) (0)
EVIDENCE FOR DISTURBED REGULATION OF 1,25-DIHYDROXYVITAMIN D3 IN EARLY CHRONIC RENAL FAILURE (1991) (0)
Pharmacokinetics of muzolimine after acute and chronic dosing in hypertensive patients with mild renal insufficiency. (1985) (0)
[Vascular access for hemodialysis: will the tunnelled atrial catheter solve the problems?]. (2004) (0)
Mineralocorticoid receptor blockade—a novel approach to fight hyperkalaemia in chronic kidney disease (2013) (0)
[Reversible thrombopenia in the clinical use of antilymphocyte serum]. (1971) (0)
The kidney as a cause and tar get of hypertension (0)
Fifth Baltic Nephrology Conference jointly organized by the Baltic Societies of Nephrology and the Joint Action Nephrology in Eastern Europe, a collaborative effort of ISN and ERA (2001) (0)
[Dyslipoproteinemia: its importance in nephrology]. (1993) (0)
GLOMERULAR FILTRATION RATE (GFR) DETERMINES METABOLIC CLEARANCE RATE (MCR) OF HGH (1993) (0)
Reversal of glomerulosclerosis — quantitative analysis of different glomerular cells and glomerular capillarisation (2004) (0)
[Uremia and proliferation of the gastric mucosa, autoradiographic studies on interim phases of the cell cycle and the generation time of the gastric mucosa in uremic rats]. (1971) (0)
[Glucuronic acid pathwayof glucose catabolism in aortas of alloxan-diabetic animals]. (1969) (0)
Is control of secondary hyperparathyroidism optimal with the currently used calcium concentration in the CAPD fluid? (1992) (0)
[The present status of renal transplantation]. (1971) (0)
African Americans compared to Senegalese--same number of glomeruli, but greater glomerular size. What does this tell us? (2010) (0)
[Proceedings: Morphological studies on the pathogenesis of uremic epiphysiolysis]. (1973) (0)
[Induction of bradycardia by mibefradil in antihypertensive combination therapy]. (1998) (0)
Controversy: immunotherapy in glomerulonephritis indicated or not? (1988) (0)
New article: 978-3-8055-3914-25_284.pdf (1985) (0)
2P-0423 LDL subfraction profile at baseline in a double-blind clinical trial with atorvastatin in patients with type 2 diabetes on hemodialysis (Die Deutsche Diabetes Dialysis Study) (2003) (0)
Ca transport of sarcoplasmic reticulum during experimental uremia (1975) (0)
[Incidence of bacteriuria in hormonal contraception]. (1976) (0)
[Renal effects of angiotensin-converting enzyme inhibitors and their therapeutic use in chronic terminal renal failure]. (1988) (0)
A new dawn in cardiovascular protection: total cardiovascular risk: rigorous treatment of risk factors. Introduction. (2008) (0)
Renal pressure-natriuresis relationship. (1993) (0)
[Hemofiltration for the treatment of hypertension in dialysis patients: behavior of the sympathetic nervous system]. (1978) (0)
Hypertension and kidney disease: a combination that should be prevented. (2009) (0)
Stimulation of cardiac contractility by catecholamines is diminished in experimental uremia. (1984) (0)
Approaches in the Management of Patients with Chronic Kidney Disease and Cardiovascular Disease (2010) (0)
[Intestinal calcium transport in uremia]. (1969) (0)
Professor F. Kokot, Katowice, Poland (1994) (0)
Actions of 25(OH)2D3 on vascular smooth muscle cells (VSM) (1986) (0)
[New aspects of endocrine regulation of calcium metabolism]. (1988) (0)
[Osteopathy in long-term dialysis. Diagnostic parameters and pathogenetic factors]. (1972) (0)
Renal morphology in the diabetic animal models: streptozotocin and SHR/N-cp (2004) (0)
[Changes in glucose degradation in rabbit aortae under the influence of biguanides]. (1968) (0)
[Acute myoglobinuric kidney failure as a consequence of autoaggressive behavior in mental retardation]. (1994) (0)
DO CHANGES IN PHOSPHATE BALANCE MODULATE l,25(OH)2D3 LEVELS IN HEALTHY CONTROLLS AND IN PATIENTS WITH EARLY RENAL FAILURE ? (1991) (0)
Nephrology Grand Rounds Clinical Issues in Nephrology (1998) (0)
OFFSPRING OF MOTHER RATS EXPOSED TO CIGARETTE SMOKE CONDENSATE ARE CHARACTERIZED BY ELEVATED BLOOD PRESSURE AND REDUCED SODIUM URINARY EXCRETION: 5D.07 (2011) (0)
[Experiences and data in sibling kidney transplantation (proceedings)]. (1976) (0)
Inhibition of sympathetic activity modulates gene expression in chronic renal failure (2003) (0)
Pathophysiology of renal disease (1982) (0)
MATERNAL SALT INTAKE– BLOOD PRESSURE AND TARGET ORGAN MORPHOLOGY IN THE OFFSPRING: 7D.03 (2010) (0)
FP074THE INFLUENCE OF CYCLOSPORINE A IN PREGNANT RATS ON HEART STRUCTURE IN THE ADULT OFFSPRING (2015) (0)
Supplemental low-protein diet in chronic renal failure. (1984) (0)
Nephroquiz for the Beginner. Look at the face and you have the diagnosis. This patient suffered from epulis. (1998) (0)
[Calcium transport in uremia. Studies on isolated sarcoplasmic reticulum in striated muscles]. (1978) (0)
The message for World Kidney Day 2009: hypertension and kidney disease--a marriage that should be prevented. (2009) (0)
Lead Nephropathy. (1987) (0)
[Letter: Hemodialysis in malignant hypertension]. (1975) (0)
[Diuretics for the treatment of edema]. (2006) (0)
Report on the nephrology summer school in Budapest, 31 May--1 June 1996 (1996) (0)
[Drug treatment of chronic glomerulonephritis: contra]. (1985) (0)
Approaches to the management of renal bone disease (1996) (0)
Serum cortisol predicts increased cardiovascular mortality in patients with acute coronary syndrome: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study (2010) (0)
The role of angiogenic factors in the genesis of maladaptative capillary growth in uremic left ventricular hypertrophy (2004) (0)
[Micromorphometric analysis of growth plates in experimental hypo- and hyperthyroidism (author's transl)]. (1974) (0)
Priorities in dialysis, July 1994, Vienna, Austria (1995) (0)
Cholesterol absorption predicts the effectiveness of atorvastatin for preventing cardiovascular end points in diabetic hemodialysis patients (2014) (0)
[Type II diabetes. Pathophysiology of insulin resistance, rules and goals of therapy]. (1995) (0)
Rapid changes in phosphoinositide metabolism and calcium uptake induced by 1,25-dihydroxyvitamin D3 in myoblasts (1992) (0)
Nephrology Dialysis Transplantation Prevalence of dialysis-related amvloidosis in diabetic patients (2005) (0)
[Malignant hypertension]. (1983) (0)
Characterization of 25-hydroxyvitamin D3 receptors in cytosol and nuclear extracts from the hypercalcemic Walker carcinosarcoma 256 (1984) (0)
[Disorders of calcium and phosphate homeostasis]. (1998) (0)
Contents, Vol. 14, 1994 (1993) (0)
Blood pressure on referral and blood pressure achieved Patients and methods (1998) (0)
Incidence of bacteriuria in connection with hormonal contraception (1976) (0)
Introduction to 'Integration of the response to dietary potassium load: a paleolithic perspective'. (2014) (0)
[Experimental micromorphometric studies on uremic osteodystrophy]. (1970) (0)
[Histochemical studies on the formation of mucoid substances in the gastric mucosa in uremia]. (1973) (0)
Micromorphometric and microradiographic studies of the growth apparatus of normal and diseased children (1974) (0)
Antibody-Coating bei Harnwegsinfekten (1978) (0)
Postersession I: Endokrinologie (1984) (0)
Contents, Vol. 4, 1984 (1984) (0)
Mehls , Ritz , Krempien , Gilli , Link , Willich , and Scharer TABLE I Primary renal disease in 112 children with chronic renal failure (2006) (0)
Update in nephrology Beograd, 12 February 2000. (2000) (0)
Drug Therapy in Renal Failure and Dialysis -A Critical Evaluation of the Necessities (1985) (0)
Epidermal basal cells: another non-classical target organ for 1,25(OH)2D3 (1985) (0)
[Nephropathy: an overview for daily practice]. (2003) (0)
INFLUENCE OF ACE INHIBITION ON INSULIN RESISTANCE. AUTHORS' REPLY (1995) (0)
Development of the circadian clockwork in the (2014) (0)
[Management of slipped epiphyses in renal osteodystrophy (author's transl)]. (1976) (0)
Soluble Fibrin Monomer Complexes in Patients with Renal Cell Carcinoma (1977) (0)
Osteomyelitis of both femora in a patient on maintenance hemodialysis with severe uremic osteopathy (2004) (0)
[Diagnosis of diabetic nephropathy]. (1985) (0)
[Phospholipid synthesis in the normal and arteriosclerotic human vascular wall]. (1971) (0)
Contents, Vol. 3, 1985 (1985) (0)
[Therapy of acute kidney failure]. (1984) (0)
[PP.23.06] INFLUENCE OF CYCLOSPORINE A ADMINISTRATION IN PREGNANT RATS ON BLOOD PRESSURE AND HEART STRUCTURE IN THEIR OFFSPRING (2017) (0)
Look at the face and you have the diagnosis (1998) (0)
Drug therapy in dialysis patients. (1986) (0)
Title Page / Contributions to Nephrology / Contents / Preface (1984) (0)
[Neoangiogenesis: from molecular biology to clinical medicine]. (2003) (0)
[Research on the metabolism of acid mucopolysaccharides in normal and arteriosclerotic changed fresh human arteries]. (1968) (0)
Kidney Function in Congestive Heart Failure (2009) (0)
[Thiazide (TH) therapy in idiopathic hypercalciuria (IHC)--effect on parathyroid hormone (PTH) secretion]. (1978) (0)
Management of proteinuric nephropathies (2002) (0)
[Calcium metabolism in secondary hyperparathyroidism]. (1968) (0)
Viral hepatitis A and B in hemodialysed patients (1980) (0)
International one-day Nephrology Update. (2001) (0)
PDGF and TGF-J 3 contribute to the natural course of human IgA glomerulonephritis Z 0 (2015) (0)
Homeostasis of phosphate and other minerals : [proceedings of the Third International Workshop on Phosphate and Other Minerals held at the Fundación Jiménez Díaz, Madrid, Spain, July 15-18, 1977] (1978) (0)
[Insulin--a side issue or indeed the cause of hypertension?]. (1991) (0)
NON‐CORONARY HEART DISEASE IN DIALYSIS PATIENTS: Non‐coronary Heart Disease in the Dialysis Patient—Introduction (2008) (0)
[Tubular functional disorders in diseases of the renal parenchyma]. (1979) (0)
SKELETAL MANIFESTATIONS OF RENAL OSTEODYSTROPHY IN CHILDREN (1980) (0)
Alcohol and kidney damage (2012) (0)
Disturbed calcium metabolism in renal failure-from molecular analysis to clinical management (1995) (0)
High salt intake in pregnancy alters maturation of glomeruli in the rat offspring (2012) (0)
[Inhibition of the progression of renal failure in glomerular diseases]. (1993) (0)
Cardiovascular Death in Uremia—More Complex Than We Thought (2008) (0)
[Disorders of calcium-, phosphorus-, and magnesium balance]. (1977) (0)
[Fatty acid oxidation in rat aorta]. (1968) (0)
Nephrolithiasis in patients on maintenance hemodialysis (1978) (0)
Issues in glomerulonephritis and renin system. (1984) (0)
[Changes in the cortical structure of the femur in secondary hyperparathyroidism and its effect on the biomechanics of bone tissue]. (1974) (0)
[Proceedings: Osteopathies and calcium metabolism]. (1974) (0)
[Kidney transplantation. Report on experience with the Heidelberg transplantation program 1967-68]. (1968) (0)
Clinical significance of angiotensin II receptor antagonists in patients with diabetes mellitus - Wrong interpretation (2002) (0)
Hemostatis Disorder Under Penicillin G Therapy (1977) (0)
[Destructive spondylarthropathy in dialysis patients]. (1991) (0)
Abstracts of The Japanese Journal of Nephrology (1980) (0)
[Methods and value of roentgen diagnosis in systemic bone diseases]. (1977) (0)
Gonadal 1 25 di hydroxy vitamin d 3 receptor and action of 1 25 di hydroxy vitamin d 3 on luteinizing hormone stimulated testicular and ovarian cyclic amp response (1982) (0)
[Skeletal histology in uremic osteodystrophy following increase of dialysate calcium concentration to 3,75 mval-1 (preliminary report)]. (1973) (0)
NEPHROLOGY GRAND ROUNDS Malignancy After Renal Transplantation (2002) (0)
CHEMISTRY RESULTS IN RECURRENT STONE-FORMERS (1976) (0)
The Message for World Kidney Day 2009 (2009) (0)
[Renal effects of conversion enzyme inhibitors]. (1991) (0)
[Polycystic kidney disease: recent developments]. (1987) (0)
[Hypercalciuria in patients with oxalate-calculi: suppression of parathyroid glands through the intestinal hyperabsorption of calcium]. (1976) (0)
[Treatment of the diabetic with terminal renal failure]. (1983) (0)
[Current state (Nov. 15, 1970) of kidney transplantation in the German Federal Republic and in West Berlin]. (1972) (0)
[This also applies to diabetic patients: no fear of beta blockers]. (2002) (0)
[Experimental studies on "uremic gastritis"]. (1975) (0)
[Urokinase; protein-chemistry and fibrin-autography studies]. (1972) (0)
[Glomerular hyperperfusion and kidney insufficiency]. (1994) (0)
[Demonstration of transplanted human kidney using thermography]. (1973) (0)
Moxonidine, a sympatholytic drug that modulates gene expression in chronic renal failure (2002) (0)
[Hypercoagulability in patients treated with hemodialysis (diagnosis and therapy)]. (1971) (0)
[Changes in myocardial function and calcium metabolism produced by uremic metabolic conditions]. (1977) (0)
Nephropathy in NIDDM — an update (1998) (0)
Postersession II: Nephrologie 2 (1984) (0)
[Conversion enzyme inhibitors in the antihypertensive treatment of patients with renal insufficiency]. (1987) (0)
Hemodialysis in Type I and Type II Diabetic Patients with Endstage Renal Failure (1998) (0)
57 Hypertension in Patients with Glomerulonephritis - Dependence on Renal Disease, Age and Renal Function (1984) (0)
[High blood pressure and kidney diseases--an unhealthy combination]. (2009) (0)
[How worthwhile is "survival"? Dialysis in kidney patients--results and problems]. (1971) (0)
Impaired hormonal stimulation in isolated hepatocytes of phosphorous depleted rats. (1984) (0)
Current controversies in blood pressure in diabetic nephropathy (1999) (0)
[Cytomegaly-virus infection in hemodialysed patients]. (1971) (0)
Hemodialysis and CAPD in Type I and Type II Diabetic Patients with Endstage Renal Failure (2000) (0)
[Pulmo-renal syndrome. An unusual course of Wegener disease]. (1983) (0)
招聘講演2 Nephrology in type 2 diabetes (1999) (0)
Professor Dr Günther Stein (Jena), 65th birthday (2002) (0)
[Diagnosis of anticonvulsant osteomalacia in adults (author's transl)]. (1977) (0)
Reply by Editor (1996) (0)
[Diabetic patients with increased blood pressure in family practice. 38% already have microalbuminuria!]. (2003) (0)
[Handskeleton studies with mammography technique in patients under antiepileptic medication (author's transl)]. (1977) (0)
[10 minute consultation: hypokalemia as incidental finding]. (2004) (0)
Analgesic nephropathy. (1996) (0)
[Energy metabolism in the heart of uremic animals]. (1976) (0)
Effects of estrogen on cardiovascular structure in the spontaneously ovarectomized SHRsp rat (2004) (0)
[Hyperinsulinemia. Current thinking on cardiovascular risks]. (1990) (0)
Lab methods, progression & risk factors for CKD - 3 (2009) (0)
Postersession V: Hypertonie (1984) (0)
[Secondary hyperparathyroidism]. (2001) (0)
[Therapeutic measures in recurrent calcium oxalate nephrolithiasis]. (1978) (0)
DOES EXPOSURE OF PREGNANT RATS TO CIGARETTE SMOKE CONDENSATE INFLUENCE BLOOD PRESSURE AND PODOCYTES NUMBER IN THEIR OFFSPRING?: PP.9.349 (2010) (0)
[Osteopathy in maintenance hemodialysis (author's transl)]. (1972) (0)
[Diuretics and electrolytes]. (2000) (0)
[RAS blockade in diabetic nephropathy. "Early intervention can dramatically decrease loss of function]. (2004) (0)
PREVENTION OF MICROALBUMINURIA: EFFECT OF BASELINE UACR AND CHANGES IN THE EGFR ON OUTCOME (ROADMAP TRIAL): 7E.09 (2011) (0)
[Morphology of uremic gastritis]. (1971) (0)
DOES AN INDEPENDENT ASSOCIATION BETWEEN VITAMIN D AND PLASMA RENIN CONCENTRATION MODULATE CARDIOVASCULAR MORTALITY?: 5C.05 (2010) (0)
[Changes in the myocardial metabolism in the hearts of uremic animals]. (1975) (0)
Cardiovascular Problems in Chronic Kidney Disease (2009) (0)
Japanese European Nephrology Forum: an initiative to promote scientific exchange between Japan and Europe (1998) (0)
[Indications and counterindications for organ transplantation]. (1970) (0)
Nephrology Dialysis Transplantation Expression of receptors for advanced glycation end-products in occlusive vascular and renal disease (2005) (0)
[Growth disorders in experimental hypothyroidism]. (1974) (0)
Section Review: Cardiovascular & Renal: Angiotensin converting enzyme inhibitors and nephroprotection (1995) (0)
Values Over a Broad Range Aldosterone/Renin Ratio Determines Peripheral and Central Blood Pressure (2011) (0)
Change of parathyroid cell 1,25(OH)2D3 receptors in uremia (1986) (0)
The Joint Society of Nephrology in Germany, Switzerland and Austria - Five Decades of Successful Activities. (2016) (0)
Tumour-like calcinosis causing reversible tetraparesis in a patient on continuous ambulatory peritoneal dialysis. (2001) (0)
[SH antigen in patients undergoing long-term extracorporal dialysis. Cross-sectional study in five German centers for hemodialysis]. (1970) (0)
LDL subfractions in type 2 diabetics on hemodialysis: preliminary baseline data from a prospective study investigating atorvastatin in high risk patients (2001) (0)
Cardiovascular complications in CKD 5D (2012) (0)
[The forms and diagnosis of vasculitis]. (1996) (0)
Pathophysiology of hyponatremia and pathogenesis of its associated vasopressin stimulation (1994) (0)
[Diuretics--drug treatment of choice for uncomplicated hypertension--Pro]. (2003) (0)
[Antibody coating in urinary tract infections]. (1978) (0)
[Biochemistry and clinical significance of urokinase]. (1978) (0)
[Intestinal calcium absorption in the early stage of renal insufficiency and the effect of 5,6-trans-25-OHCC]. (1977) (0)
human monocytes into macrophages expression are developmentally regulated during differentiation of 1,25-dihydroxyvitamin D3 production and vitamin D3 receptor (2011) (0)
Tribute to Professor Antony Raine. Hypertension and the kidney: the Tony Raine Memorial Symposium. Glasgow, Friday 28th June 1996. (1996) (0)
EFFECTS OF LOW-DOSE SYMPATHOLYTIC TREATMENT BY MOXONIDIN OR ALPHA- AND BETA-BLOCKERS ON CARDIOVASCULAR STRUCTURES IN RENAL HYPERTENSION: P3.157 (2004) (0)
Title Page / Contributions to Nephrology / Contents / Introduction (1982) (0)
The cardiovascular high-risk-patient in primary care - The HYDRA-study (2003) (0)
Erratum: Mineralocorticoid receptor blockade - A novel approach to fight hyperkalaemia in chronic kidney disease (Clinical Kidney Journal (2013) 6 (464-468) doi:10.1093/ckj/sft084) (2013) (0)
[Radiologic skeletal diagnosis in dialysis patients]. (1990) (0)
[Diabetic nephropathy--manage now!]. (2010) (0)
Coronary heart disease Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography (2010) (0)
[The metabolic syndrome]. (1995) (0)
WORLD KIDNEY FORUM Renal Research in 19th Century Germany (2010) (0)
Hypertension and diabetes mellitus: a risky alliance: how can drug therapy improve clinical outcome? (A panel discussion). (1997) (0)
AKI - experimental models (2013) (0)
Training problem for type II diabetics with penal failure (RF) (1994) (0)
Erectile dysfunction in nephrotic syndrome. (1992) (0)
114: Federal Republic of Germany Stimulation of thymocytes by T4 or T3 in vitro (1976) (0)
Treatment based on a very low dose combination of perindopril and indapamide reduces albuminuria more effectively than enalapril in hypertensive Type 2 diabetic patients: the PREMIER study (2002) (0)
ASSOCIATIONS OF PLASMA RENIN WITH 10-YEAR CARDIOVASCULAR MORTALITY, SUDDEN CARDIAC DEATH AND DEATH DUE TO HEART FAILURE: 4C.05 (2011) (0)
Mikroalbuminurie-Routine-Screening bei Typ-2-Diabetes mellitus - Pro (2003) (0)
[Deleterious effects of parathormone on the heart]. (2011) (0)
PPARa agonists: killing two birds with one stone? (2004) (0)
Administration of Cyclosporine A during Pregnancy Causes Elevated Blood Pressure and Reduced Glomerular Number in the Offspring (2016) (0)
Subject Index Vol. 14, 1994 (1994) (0)
[Conservative treatment of chronic kidney insufficiency in clinical practice 1989]. (1988) (0)
Monday, June 28, 2010: Free Communications (2010) (0)
[ACE inhibitors in kidney diseases--only another antihypertensive agent?]. (1994) (0)
[Cystic kidney]. (1987) (0)
[Osteopathies and calcium metabolism]. (1974) (0)
The uraemic patient with multiple small sugillations on the forehead. (1995) (0)
One alpha symposium : genesis of disturbed vitamin D metabolism in renal failure : 8th April 1994, London, UK (1995) (0)
Bone disease - 1 (2009) (0)
[Therapy of hyponatremic heart failure with glucose-insulin-potassium infusions and with demeclocycline]. (1978) (0)
Pathogenesis of Uremia (1984) (0)
Acute renal dysfunction after renal transplantation (1998) (0)
[Recent perspectives on the mechanisms of rejection in kidney transplantation (author's transl)]. (1978) (0)
[Acute renal failure and hypertension crisis after a technoparty]. (2003) (0)
Diabetes and renal disease (2013) (0)
[Phosphate values in hyperparathyroidism]. (2001) (0)
[Prophylactic measures for preventing renal osteodystrophy]. (1989) (0)
[Problems of diagnosis and therapy of osteopathy in a case of maintenance dialysis]. (1972) (0)
Decreased renal haemodynamic response to inhibition of nitric oxide synthase in subtotally nephrectomized rats (1995) (0)
[Treatment of idiopathic hypercalciuria]. (2008) (0)
Ritz Renal failure and ACE inhibition : how much is too much ? (0)
[Historical roles of salt]. (2004) (0)
MS535 HOMOARGININE INDEPENDENTLY PREDICTS TOTAL AND CARDIOVASCULAR MORTALITY IN INDIVIDUALS WITH ANGIOGRAPHIC CORONARY ARTERY DISEASE (2010) (0)
[The recurring urinary tract infection. Do immunologic factors play a part?]. (1979) (0)
[Therapy of nephrolithiasis]. (2008) (0)
Early diagnosis and prevention of kidney disease. (1997) (0)
[Hypertension following renal transplantation (author's transl)]. (1981) (0)
Urinary electrolytes in the general male population and in stone formers (1978) (0)
Blood pressure and uremic cardiomyopathy. (1988) (0)
The message for World Kidney Day 2009: hypertension and kidney disease—a marriage that should be prevented (2009) (0)
Renal Pathology Forum (1984) (0)
[Normocalcemic primary hyperparathyroidism]. (1974) (0)
Editorial Commentary The Kidney Both Culprit and Victim (2009) (0)
Curs Educational International ‘Actualitaˇţi şi perspective in Nefrologie’ jointly organized by the Societatea Romana de Nefrologie, Universitatea de Medicina si Farmacíe ‘Gr. T. Popa’, Iasi and Joint Action Nephrology Eastern Europe (ERA/EDTA/ISN) 24 June 2000 (2001) (0)
The effect of dialysate magnesium concentration on serum PTH-levels in patients on maintenance haemodialysis (2005) (0)
Consultant List (2002) (0)
Is it beneficial to treat hypertension in patients aged 80 years or older? (2008) (0)
[Bone metabolism in metabolic acidosis]. (1971) (0)
Faulty Podocyte Hypoxia Sensing — A Novel Pathway for Rapidly Progressive Glomerulonephritis Loss of the Tumor Suppressor Vhlh Leads to Upregulation of Cxcr 4 and Rapidly Progressive Glomerulonephritis (2006) (0)
The renal kallikrein-kinin system in streptozotocin diabetic rats after ACE-inhibition (1996) (0)
Non-immune and immune cells contribute to the production of TH1 and TH2 cytokines in renal allografts (1997) (0)
Nierenlebendspende (2002) (0)
Deranged vitamin D metabolism and hyperparathyroidism in lead intoxication (1987) (0)
[Proceedings: Electron microscopy studies on the pathogenesis of uremic gastropathy]. (1973) (0)
Cardiovascular Literature—Beyond Nephrology (2008) (0)
Therapeutic modalities for the prevention of nephrolithiasis. (1986) (0)
[Diagnosis and differential diagnosis of acute kidney failure]. (1984) (0)
[Diagnosis of lupus nephritis]. (2008) (0)
[Dietary aspects and nutritional guidelines in kidney diseases]. (1993) (0)
SSA (Ro)-antibodies in Wegener's granulomatosis (1983) (0)
[Ambulatory 24-hour blood pressure monitoring of children and young adults with autosome dominant polycystic kidney degeneration]. (1992) (0)
[Changes of striated muscles in experimental uremia]. (1973) (0)
[Transmission of Australia antigen by insects (Platta americana)--a possible way of infection in homologous serum hepatitis]. (1972) (0)
[Bone-formation rate and bone-resorption rate in renal insufficiency. An experimental study on the pathogenesis of renal osteopathy]. (1972) (0)
[Arterial hypertension in patients after kidney transplantation]. (1986) (0)
CHANGES OF 1,25(OH)2D3 RECEPTOR EXPRESSION IN DIFFERENT STAGES OF GROWTH PLATE CHONDROCYTES MATURATION (1991) (0)
Serum transaminases and serum zinc in dietary liver cirrhosis in rats; observations on the course. (1971) (0)
Statins: do we definitely know whether they are completely inefficacious in ESRD? (2010) (0)
Nephrology Dialysis Transplantation Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure (2005) (0)
Cardiovascular Disease and Inflammation (2021) (0)
PREVENTION OF MICROALBUMINURIA: PREDICTORS FOR A GOOD RESPONSE TO OLMESARTAN TREATMENT (ROADMAP TRIAL): PP.16.85 (2010) (0)
Race: a call to change nomenclature. (2009) (0)
[Proceedings: Micromorphometric and microradiographic studies on the growth apparatus of the femur and tibia in healthy and sick children]. (1974) (0)
Abnormalities of Calcium, Phosphate, and Magnesium Metabolism (1989) (0)
[Indication for kiney transplantation]. (1972) (0)
system in rats with experimental nephritis retinoic acid on renin-angiotensin trans Effects of all- (2016) (0)
[Indications and contraindications in the organ transplantation]. (1970) (0)
[Modern examination methods in secondary hyperparathyroidism]. (1968) (0)
Associations of resting heart rate with insulin resistance, cardiovascular events and mortality in chronic kidney disease (2009) (0)
Vitamin D and nephrology Reply (2012) (0)
Subject Index, Vol. 4, 1984 (1984) (0)
THE NOVEL FIBROSIS MARKER GALECTIN 3 ASSOCIATES WITH INFECTIOUS DEATHS , ALL-CAUSEMORTALITY AND CARDIOVASCULAR EVENTS IN HEMODIALYSIS PATIENTS (2013) (0)
[Kidney function in lead burden]. (1986) (0)
Physiological doses of calcium regulatory hormones do not normalize bone cells in experimental uremia (1996) (0)
Receptors for and action of 1,25-dihydroxyvitamin D3 in submammalian animals (1989) (0)
[Readjustment of severe hypertension with captopril]. (1983) (0)
Experimental pathology - 1 (2009) (0)
Is angioaccess a limiting factor for haemodialysis of diabetic patients (1983) (0)
SH-antigen in patients on long-term dialysis. (1970) (0)
Secondary hyperparathyroidism. (1992) (0)
Immunoregulatory (antiidiotypic?) serum factors in pre- and posttransplant sera of renal transplant recipients (1988) (0)
Title: Vitamin D, cardiovascular disease and mortality (2011) (0)
[Why is there a type-2 diabetes?]. (1993) (0)
Effect of a Selective Endothelin Receptor A Blocker on Cardiovascular Remodeling in Uninephrectomized Spontaneously Hypertensive Rats of the Stroke-Prone Strain (2007) (0)
[In what way and how intensively should blood pressure be lowered in diabetic nephropathy?]. (1997) (0)
[Progression of chronic renal failure: causes and modification]. (1988) (0)
Estrogens influence antibody coating in experimental urinary tract infection (1983) (0)
Clinical Nephrology (2008) (0)
[Diagnosis and therapy in systemic vasculitis with renal involvement]. (1994) (0)
4: Growth and bone histology in experimental uremia (1976) (0)
DISEASE OF THE MONTH (2000) (0)
Phosphate metabolism : [proceedings of the second international workshop on Phosphate held in Heidelberg, Germany, June 28-30, 1976] (1977) (0)
Salt appetite and addiction--unholy twins? (2012) (0)
OSTEOCALCIN (OC) IN ADOLESCENTS WITH ADVANCED RENAL FAILURE (1988) (0)
EFFECT OF VITAMIN D3 AND 1, 25 (OH)2 D3 ON GROWTH IN EXPERIMENTAL UREMIA (EU) (1980) (0)
[Histochemical studies of gastric mucosa synthesis of mucous materials in uremia]. (1973) (0)
Hypertension after renal transplantation. (2001) (0)
Uric acid - a renal and non-renal risk factor (2013) (0)
Oral Sessions (2007) (0)
[Australia-SH antigen in patients undergoing hemodialysis]. (1971) (0)
1,25(OH)2D3 RECEPTOR EXPRESSION AND l,25(OH)2D3 ACTION ON MESANGIAL CELL PROLIFERATION (1991) (0)
[Therapy of diabetic nephropathy]. (2008) (0)
The prevalence of microalbuminuria in a nationally representative sample of primary care attendees: focus on patients with diabetes (2003) (0)
[Serum transaminases and serum zinc in dietetic induced liver cirrhosis of the rat--observations of the course]. (1971) (0)
[Hypertension in the aged]. (1985) (0)
Cardiovascular complications - 1 (2009) (0)
B-Type Natriuretic Peptide Concentrations Predict the Progression of Nondiabetic Chronic Kidney Disease: The Mild-to-Moderate Kidney Disease Study and (2007) (0)
[Raynaud's phenomenon in dialysed patients (author's transl)]. (1977) (0)
History of d iabetic n ephropathy: a p ersonal a ccount (2013) (0)
Reply by the Editors to the letter of Professor A Bensman (1995) (0)
[New aspects of calcium metabolism in kidney calculus disease]. (1988) (0)
The frequency of bacteriuria when hormonal contraception is used (1975) (0)
Age-dependent changes of vitamin D status and 1,25(OH) 2 D 3 receptor expression in spontaneously hypertensive (SH) rats (1988) (0)
Effects of 1,25(OH)2D3-pulses on cultured growth plate chondrocytes of the rat (1992) (0)
Erratum: Morbidity, mortality and quality of life in the ageing haemodialysis population: results from the ELDERLY study (2017) (0)
[Studies on the rate of assimilation of radioactively marked sulfate into acid mucopolysaccharides of human blood vessel walls]. (1968) (0)
[Antihypertensive therapy in diabetic patients. Almost as important as controlling blood glucose]. (2000) (0)
[Requirements for the development of a kidney transplantation program]. (1969) (0)
Wegener's granulomatosis, microscopic polyarteritis and pauciimmune crescentic necrotizing glomerulonephritis. An overview. (1991) (0)
Special Features Special feature on the occasion of the 25 th anniversary of NDT (2010) (0)
Effects of 1,25-Dihydroxyvitamin D3 on intracellular Ca2+ in cultured mesangial cells (1992) (0)
Randomized Olmesartan And Diabetes Microalbuminuria Prevention Study (ROADMAP). (2011) (0)
Acquired Cystic Kidney Disease (1990) (0)
Retarding loss of renal function after onset of nephropathy. (1990) (0)
[World Kidney Day 2011: Renal protection - a matter close to one's heart]. (2011) (0)
Benefit of a treatment strategy based on a very low dose combination of perindopril and Indapamide in albuminuric hypertensive type 2 diabetics (2002) (0)
[Hemodialysis after injection of contrast media--useful, harmful or ineffective?]. (2001) (0)
[Immunogenetics of mesangial IgA glomerulonephritis and Schönlein- Henoch purpura]. (1989) (0)
[Nephrology update. Kidney protection with antihypertensive drugs: I]. (2002) (0)
Abnormal vitamin D metabolism and parathyroid hyperplasia in genetically hypertensive rats (1988) (0)
Diabetes mellitus - clinical studies - 1 (2009) (0)
[Hypergonadotropic hypogonadism in kidney failure--a consequence of disorders of testicular cyclic AMP formation]. (1978) (0)
[Osteopathy in long-term dialysis. II. Radiological skeletal changes]. (1971) (0)
Introduction to Calcium Symposium (1973) (0)
Epidemiology and Prevention Homoarginine, Cardiovascular Risk, and Mortality (2010) (0)
[Carbenicillin induced disturbance of platelet function: a study in patients with normal renal function (author's transl)]. (1977) (0)
Comment from the Editorial Office (1995) (0)
[Cell-mediated immunoreactivity in patients with chronic kidney insufficiency]. (1977) (0)
Do osteoclasts directly respond to 1,25(OH)2 vitamin D3? (1986) (0)
[Secondary hyperparathyroidism in renal insufficiency. Prevention and therapy]. (1976) (0)
Genetic diseases and molecular genetics (2013) (0)
Haemodialysis in Type 1 and Type 2 Diabetic Patients with end Stage Renal Failure (1994) (0)
Hormonal disturbances of calcium metabolism in renal failure. (1993) (0)
Treatment in Advanced Renal Disease in Type 1 and Type 2 Diabetes (2006) (0)
Hypertension as a Major Risk Factor in Diabetic Patients on Hemodialysis and CAPD (1988) (0)
Subject Index, Vol. 3, 1985 (1985) (0)
ABNORMAL 1,25(OH)2D3 RECEPTOR RELATION OF PARATHYROID GLAND IN LEAD INTOXICATION (1988) (0)
[Immunotherapy of primary glomerulonephritis]. (1989) (0)
Different pulsatile leptin secretion after intravenous CRH in hemodialysis patients and healthy subjects (2000) (0)
[Regression of renal ostitis fibrosa through permanent dialysis]. (1968) (0)
Management of Essential Hypertension (2009) (0)
Special feature on the occasion of the 25th anniversary of NDT. (2010) (0)
Hypertension and diabetes screening and awareness study (hydra): Prevalence, comorbidity and pharmacological treatment patterns of hypertension and diabetes in primary care in Germany (2003) (0)
Effect of a high molecular weight fraction of normal urine on bone cell metabolism. (1975) (0)
GALECTIN-3 AND ADVERSE OUTCOMES IN CHRONIC KIDNEY DISEASE - RESULTS FROM THE LURIC AND THE 4D STUDY (2014) (0)
Erratum to: Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study (2009) (0)
[Experimental studies of intestinal calcium transport in uremia]. (1970) (0)
[Routine screening for microalbuminemia in type 2 diabetes mellitus--pro]. (2003) (0)
Smoking - the lost fight against the vice (2005) (0)
Attenuated metabolic and increased renal effects of angiotensin II (ang II) in early type 2 diabetes mellitus (NIDDM) (1997) (0)
Book Review / Varia (2004) (0)
Retinoic acids inhibit angiotensin II-dependent effects in vascular smooth muscle cells: role of AP-1 (2000) (0)
[Protein restriction in chronic kidney insufficiency]. (1991) (0)
[Proceedings: Normocalcemic primary hyperparathyroidism]. (1974) (0)
[Experimental studies on parathyroid hormone resistance of the skeleton in kidney insufficiency]. (1977) (0)
Herz Kidney and Hypertension – Causes Update 2003 (0)
[Hypertension and the kidney]. (1997) (0)
[Current therapy of chronic kidney insufficiency]. (1991) (0)
[Table computer program for "Diehl Alphatronic" for the recognition of calcium and phosphate metabolism disorders]. (1975) (0)
The Message for World Kidney Day 2009 (2009) (0)
rathypertrophy in the subtotally nephrectomized (2016) (0)
[Problem of the changed excretory rhythm in the transplanted kidney]. (1969) (0)
[Diuretics in therapy of hypertension?]. (1997) (0)
History of Diabetic Nephropathy: A Personal Account (2012) (0)
Renal development and cystic diseases (2011) (0)
REVERSAL OF GLOMERULOSCLEROSIS BY COORDINATE RESTRUCTURING OF GLOMERULAR MICROVASCULATURE: 4B.2 (2004) (0)
RETINOIC ACID INHIBITS ANGIOTENSIN II ACTIONS IN VASCULAR SMOOTH MUSCLE CELLS VIA ACTIVATOR PROTEIN-1: 1C.6 (2000) (0)
In-Depth Bariatric surgery and the kidney — much bene ﬁ t, but also potential harm (2013) (0)
SAFETY AND SILICONE (1981) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Eberhardt Ritz?

Eberhardt Ritz is affiliated with the following schools: